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Global populations are shifting, and the number of individuals over the age of 60 is 
rapidly increasing.  People of advanced age (>60 years old) are at risk for several chronic 
degenerative diseases.  In order to improve the quality of life for the elderly living with age-
associated diseases, and to minimize medical costs associated with an aging global population, it 
is critical to understand the molecular mechanisms that underlie aging.   
Aging is characterized as the loss of tissue function and the decreased ability to maintain 
homeostasis, which leads to an increased risk of morbidity and mortality.  The time-dependent 
accumulation of damage to cellular macromolecules is hypothesized to contribute to age-related 
decline.  However, there is no consensus about the type(s) of damage that drive aging.  There is 
evidence to support the hypothesis that DNA damage plays a causative role in aging. This 
includes mice and humans with defective DNA repair that exhibit symptoms of accelerated 
aging.  Additionally, DNA damage can induce cellular senescence, and senescent cells are 
thought to contribute to age-associated functional decline. However, direct causal relationships 
between senescence and aging, and DNA damage and aging have yet to be established.   
The overall goal of this thesis was to address these gaps in knowledge. This required the 
testing of two hypotheses. First, that the accelerated aging seen as a consequence of defects in 
DNA repair is similar to normal aging at the molecular, cellular and whole tissue level.  Second, 
that spontaneous DNA damage that occurs in cells is sufficient to drive cellular senescence.  To 
test these hypotheses, I employed a genetic approach, utilizing mice and primary cells that were 
engineered to be defective in the DNA repair endonuclease, ERCC1-XPF.  Hence, mice and cells 
with reduced expression of ERCC1-XPF accumulate a variety of DNA lesions compared to wild 
type mice and cells. This thesis is divided into two main sections, which take an in vivo and in 
vitro approach to testing the hypothesis that endogenous DNA damage can promote aging.   
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1.0  INTRODUCTION 
The 21
st
 century has brought a global demographic shift, such that the number of 
individuals over the age of 60 is increasing rapidly in developed and non-developed nations.  In 
1950, there were approximately 205 million persons over age 60 globally.  By 2050 that number 
is predicted to reach 2 billion[1].  Old age is the greatest risk factor for numerous chronic 
degenerative diseases, including cardiovascular disease, arthritis, cataracts, osteoporosis, type 2 
diabetes, and neurodegenerative disorders such as Alzheimer’s disease and Parkinson’s disease.  
Eighty percent of individuals over the age of 65 have at least one chronic disease and >50% have 
two or more.   In the United States alone, the direct medical costs associated with these diseases 
total nearly 1 trillion dollars annually (Table 1).   In order to improve the quality of life for the 
elderly, and to minimize the economic burden from the medical care of the aged population, it is 
critical to identify the molecular mechanisms that underlie aging.   
Table 1. Prevalence of age-related diseases in the United States 
 
 
DISEASE 
TOTAL # OF 
AFFECTED 
INDIVIDUALS IN 
THE U.S. 
% OF PEOPLE 
AGED 65+ THAT 
ARE AFFECTED 
U.S. ANNUAL 
HEALTH CARE 
COSTS 
(DIRECT) 
 
 
REFERENCES 
Cardiovascular disease 83 million 43% $444 billion [2] 
Cancer (all types) 11.7 million 2.2% $103 billion [3] 
Osteoarthritis 26.9 million 33.6% $15 billion [4] 
Ocular disorders 
(cataracts, glaucoma)  
24.3 million 21.8% $51.4 billion [5, 6] 
Osteoporosis 10 million 30% $13.7-20.3 billion [7, 8] 
Type 2 Diabetes 26 million 27% $116 billion [9] 
Alzheimer’s disease 5.4 million 13% $183 billion [10] 
Parkinson’s disease 1 million 1% $5.6 billion [11] 
TOTAL   $931.7-938.3 billion  
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Aging is characterized by the loss of tissue function and the decreased ability to maintain 
homeostasis.  This leads to an impaired ability to respond to stress and a dramatically increased 
risk of morbidity and mortality[12].  Time-dependent accumulation of damage to cellular 
macromolecules and organelles is thought to contribute to aging.  However, there is no 
consensus about the type(s) of damage that drive aging.  There is evidence to support the 
hypothesis that DNA damage is one type of damage that plays a role in aging.  This includes the 
fact that defects in the repair of DNA damage leads to accelerated aging in humans and mice[13, 
14].  Additionally, DNA damage can induce cellular senescence[15]. The number of senescent 
cells is increased in aged humans, primates, and rodents compared to young organisms[16-18].  
Furthermore, senescent cells are localized at sites of age-associated pathologies, suggesting that 
senescent cells contribute to age-associated functional decline[19].   However, direct causal 
relationships between senescence and aging, and DNA damage and aging have yet to be 
established.   
The overall goal of my thesis was to address these gaps in knowledge. This required the 
testing of two hypotheses. First, that the accelerated aging seen as a consequence of defects in 
DNA repair is similar to normal aging at the molecular, cellular and whole tissue level.  Second 
that DNA damage that occurs spontaneously in cells is sufficient to drive cellular senescence.  
To test these hypotheses, I employed a genetic approach, utilizing mice and primary cells that 
were engineered to be defective in DNA repair, in order to specifically focus on the 
physiological effect of unrepaired, endogenous DNA damage. ERCC1-XPF is an endonuclease 
involved in nucleotide excision repair of bulky, helix-distorting monoadducts, the repair of DNA 
interstrand crosslinks, and the repair of a subset of double-strand breaks.  Hence, mice and cells 
with reduced expression of ERCC1-XPF accumulate increased levels of a variety of 
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spontaneous, endogenous DNA lesions. This thesis is divided into three main sections, which 
take an in vivo and in vitro approach to testing the hypothesis that endogenous DNA damage can 
promote aging.   
In the first chapter, I examine the role of physiological role of ERCC1-XPF in specific 
DNA repair pathways, and the consequences of deficiency of ERCC1-XPF in humans and mice.  
The second chapter examines the effect of spontaneous, endogenous DNA damage in vivo.  The 
approach I took was to systematically compare the time-dependent molecular, structural and 
functional changes that occur in the liver of DNA repair deficient Ercc1
-/Δ 
mice, which 
accumulate DNA damage more rapidly than DNA repair proficient organisms, to the changes 
that occur in liver with aging in wild-type mice.  In the third chapter, I examine the effect of 
spontaneous, endogenous DNA damage on primary cells in vitro.   Physiological levels of DNA 
damage were sufficient to drive cellular senescence in vitro and in vivo.  Furthermore, in vivo, 
we discovered a highly significant correlation between the molecular, cellular and functional 
changes in the liver of young adult ERCC1-deficient mice and old wild-type mice, providing 
strong evidence that DNA damage does promote aging. An unexpected finding was that, 
ERCC1-deficient cells exhibit profound mitochondrial dysfunction, which may reinforce the 
senescent state through increased production of reactive oxygen species.    
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1.1 PHYSIOLOGICAL ROLES OF ERCC1-XPF 
Chapter 1 is adapted, with copyright permission, from Elsevier Limited, from a published review 
article.  Gregg, SQ, Robinson, AR, and Niedernhofer LJ.  (2011) Physiological consequences 
of defects in ERCC1-XPF DNA repair endonuclease.  DNA Repair 10(7): 781-791  
 
The ERCC1-XPF complex is a structure-specific endonuclease involved in the repair of 
damaged DNA.  ERCC1-XPF performs a critical incision step in nucleotide excision repair 
(NER), and is also involved in the repair of DNA interstrand crosslinks (ICLs) and some double-
strand breaks (DSBs) [20-26].  A fraction of ERCC1-XPF is localized at telomeres, where it is 
implicated in recombination of telomeric sequences and loss of telomeric overhangs at 
deprotected chromosome ends [27, 28].  Deficiency of either ERCC1 or XPF in humans results 
in a variety of conditions, which include the skin cancer-prone disease xeroderma pigmentosum 
(XP), a progeroid syndrome of accelerated aging, or cerebro-oculo-facio-skeletal syndrome 
(COFS) [29, 30].  These diseases are extremely rare in the general population and therefore mice 
with low levels of either ERCC1 or XPF have been generated and studied extensively.  These 
murine models clearly illustrate the importance of DNA repair in preventing aging-related tissue 
degeneration.   
1.1.1 Nucleotide excision repair (NER) 
Ultraviolet light damages DNA, resulting in a myriad of lesions, most predominantly 
cyclobutane pyrimidine dimers (CPDs) and (6-4) photoproducts [31].  NER is the only 
mechanism by which these photodimers can be removed from DNA in human cells, and ERCC1-
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XPF functions as the nuclease that incises the damaged strand 5’ to the adduct [32-35].  This 
incision creates a 3’ end that is used as a primer by the replication machinery to replace the 
excised nucleotides. XPF contains the catalytic activity with its conserved nuclease domain, and 
ERCC1 is required for binding to DNA [36-40].  Defects in the proteins required for NER can 
result in xeroderma pigmentosum (XP), trichothiodystrophy (TTD), and Cockayne Syndrome 
(CS), highlighting the importance of DNA repair in preventing UV-induced skin cancer and 
developmental abnormalities.   XP is a disease characterized by extreme photosensitivity and a 
10,000-fold increased risk of cutaneous and ocular neoplasms [41].  Cells from all of the XP 
complementation groups (XP-A to XP-G, and XP-V) are hypersensitive to UV radiation [29, 42-
45].  ERCC1-XPF deficient cells are distinct from other XP patient-derived cells because of their 
extreme sensitivity to chemicals that induce DNA ICLs [26, 46-48].  Another critical piece of 
evidence indicating that ERCC1-XPF has functions distinct from NER is that ERCC1 and XPF 
knockout mice exhibit a much more severe phenotype than XPA null mice, which are completely 
deficient in NER [26, 49-52].   
1.1.2 Interstrand crosslink repair (ICL-R) 
The mechanism of DNA ICL repair in mammalian cells is not as well defined as NER.  In 
replicating cells, crosslinking agents lead to DSBs created by endonuclease(s) near the site of 
stalled replication machinery [53].In the absence of ERCC1-XPF, replication-dependent 
crosslink-induced DSBs occur, indicating that ERCC1-XPF cannot be solely responsible for 
creating these DSBs [48]. There is clear evidence that ERCC1-XPF participates in the same 
mechanism of ICL repair as the Fanconi anemia proteins. In the absence of ERCC1-XPF, 
FANCD2 is still monoubiquitylated by FANCL, but translocation of FANCD2 to chromatin is 
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impaired [54].   In addition, when FANCD2 is depleted, replication-dependent incisions of ICLs 
are dramatically reduced [55].  
Recently it was demonstrated that XPF binds SLX4, a related endonuclease, and this 
interaction is critical for ICL repair [56-59].  Fanconi anemia patients, mice deficient in ERCC1-
XPF, and Slx4(Btbd12)
-/- 
mice share many spontaneous developmental and degenerative 
phenotypes, supporting roles for all of these proteins in a common pathway and illustrating the 
dramatic consequences of failure to repair endogenous ICLs [60, 61].  Recent reports describe 
the discovery of biallelic mutations in SLX4 in two patients who exhibited clinical features of 
Fanconi anemia [62, 63].  Based on evidence that reintroduction of wild-type SLX4 into the 
patients’ cells rescued sensitivity to crosslinking agents, SLX4 is considered as a new 
complementation group of Fanconi anemia: FANCP. 
1.1.3 Double-strand break repair (DSB-R) 
Orthologs of ERCC1-XPF in lower eukaryotes such as Arabidopsis thaliana, Drosophila 
melanogaster, and Saccharomyces cerevisiae play a vital role in the repair of DSBs and meiosis 
[64-67].  The two primary mechanisms of DSB repair are non-homologous end-joining (NHEJ) 
and homologous recombination (HR).  Work in budding yeast has contributed tremendously to 
defining the role of ERCC1-XPF in DSB repair in mammalian cells. Mutation of rad10 or rad1, 
the orthologs of ERCC1 and XPF in S. cerevisiae, suppresses HR between sequence repeats [68-
70].  The function of the RAD10-Rad1 nuclease in HR is to remove non-homologous 3’ termini 
of single-stranded overhangs of broken ends to facilitate single-strand annealing, an error-prone 
sub-pathway of HR [66, 67, 70, 71].  Like single-strand annealing, there is an error prone sub-
pathway of NHEJ that utilizes short stretches of homology to join two broken DNA ends termed 
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micro-homology mediated end-joining. Rad10-Rad1 also participates in this end-joining pathway 
in yeast [72]. Yeast Mre11 and Rad1 proteins define a Ku-independent mechanism to repair 
double-strand breaks lacking overlapping end sequences [72].  Mammalian cells deficient in 
ERCC1-XPF are modestly sensitive to ionizing radiation (IR), a source of DSBs [22].  Like in 
yeast, HR and end-joining of DSBs is attenuated in ERCC1-XPF-deficient mammalian cells [23, 
73-76]  
The ERCC1/XPF endonuclease is required for efficient single-strand annealing and gene 
conversion in mammalian cells [22, 76]. Therefore, it is proposed that ERCC1-XPF nuclease 
facilitates both HR and NHEJ pathways (single-strand annealing and microhomology-mediated 
end-joining) but only if the broken DNA ends contain 3’-overhanging unmatched sequences or 
that cannot be used to prime DNA synthesis [22].   
1.1.4 Role at telomeres 
ERCC1-XPF deficiency is linked with accelerated aging, and telomere shortening is associated 
with aging, therefore it was important to understand if the nuclease impacts telomere length or 
function [77]. Telomeres in humans with mutations in XPF, or Ercc1 knockout mice, are not 
shorter than controls [27]. Furthermore, there is no difference in sister chromatid exchange at 
telomeres in the absence of ERCC1-XPF [78]. However, ERCC1 co-localizes with TRF2 at 
telomeres [27]. In a TRF2 dominant negative background, ERCC1-XPF deficient cells 
accumulate telomeric double-minutes.  This led to the conclusion that ERCC1-XPF cleaves the 
G-rich, 3’- overhang, rendering chromosomes vulnerable to end-to-end fusions [27]. Hence the 
absence of ERCC1-XPF apparently does not have a deleterious impact on telomere length or 
function. Consistent with that, correction of XP-F cells or overexpression of XPF in normal 
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human cells leads to telomere shortening [79]. Therefore, accelerated aging associated with 
ERCC1-XPF deficiency is presumed to arise from cellular senescence and cell death and not as a 
consequence of telomere-dependent replicative senescence.   
1.2 CONSEQUENCES OF DEFICIENCY OF ERCC1-XPF 
1.2.1 XPF mutations in humans 
Humans with mutations in XPF can be classified into two groups based on the clinical 
manifestations of their disease (see Table 2). The majority of XP-F patients present with mild 
symptoms of XP, which include sun sensitivity, freckling of the skin, and basal or squamous cell 
carcinomas typically occurring after the second decade of life. This is in contrast to many XP-A 
and XP-C patients, in which skin cancer occurs even before 2 yrs of age [80].  The second group 
of XP-F patients exhibit neurological deterioration in addition to their XP-like symptoms.  There 
has been one published case of a patient with mutations in XPF with dramatically accelerated 
aging [29].  The mutation in XPF, its impact on protein expression, function and subcellular 
localization are all critical determinants in the clinical manifestations [81]. Of note, all XP-F 
patients carry a missense mutation in at least one allele, and none of these affect the catalytic 
domain of the protein (Table 2). This has led to speculation that ERCC1-XPF is essential for 
human life [30]. This is supported by the observation that mice homozygous for null alleles of 
these genes are not viable except in select genetic backgrounds. 
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Table 2. Human XPF mutations 
Patient 
Code 
Mutation 
Amino Acid 
anges 
Age1 
(M or 
F) 
% UDS2 UV-S3 Neuro4 
Abnormal 
pigmentation
5 
Skin 
Carcinoma6 
Ref 
XP26BR 
Base sub 2377 (CT) 
Homozygous 
Arg799Trp 
Arg799Trp 
 15  - + + [62] 
XP32BR  
Arg589Trp 
Pro379Ser 
12 10 + (2X) - + + [62] 
XP23OS 
1bp insert 1330 
Heterozygous 
Lys455Stop482 
45 (F) 
 
10 + (4X) - + - [63] 
XP126LO Base sub 2377 (CT) Arg799Trp 22 (F) 45 + -  - 
[13,6
7] 
XP7NE  
Pro379Ser 
Silent 
28 25 + (2X) - +  [73] 
XP25KO   8 (F) 12 + (3X) - + - [66] 
XP27KO   11 (F) 12 + (2.5X) - + - [68] 
XP28KO   8 (F) 12 + (3X) - + - [68] 
XP38KO   44 (F) 20-25 + (2.3X) - + - [69] 
XP46KO   61 (F) 12 + (2.8X) - + - [66] 
XP90TO   42 (M) 12 + (3X) - + + (42) [70] 
XP92TO   40 (F) 12 + (3X) - + + (41) [70] 
XP29MA   24 (M) >5 + (6X) - + - [71] 
XP30MA   29 (M) >5 + (6X) - + - [71] 
XP42RO 
Base sub 2377 (CT) 
Homozygous 
Arg799Trp 62 (M) 22 + (2X) + (47) + + (27) [76] 
XP24BR 
Base sub 2377 (CT) 
Homozygous 
Arg799Trp 
Arg799Trp 
29 5 + (3X) + + + [73] 
XP24KY 
10bp deletion (1575) 
Base sub 2377 (CT) 
Val536Stop533 
Arg799Trp 
48 (M) 7 + (3X) + + - [74] 
XP62RO 
Base sub 2377 (CT) 
Homozygous 
Arg799Trp 
Arg799Trp 
 20 + (2X) 
+ (late 
onset) 
  [62] 
AS871  
Arg589Trp 
Deletion of Exon 3 
 15 + (2X) +   [62] 
XP51RO 
Base sub 458 (GC) 
Homozygous 
Arg153Pro 15 (M) >5 + (10X) + (6)  - [10] 
XP48DC 
Base sub 2377 (CT) 
Heterozygous 
Arg799Trp    +   [129] 
CO14TA 
Base sub 2377 (CT) 
Heterozygous 
Arg799Trp    +   [129] 
CO107TA 
Base sub 2377 (CT) 
Heterozygous 
Arg799Trp    +   [129] 
XP202DC 
Nonsense 
Splice mutation in 
ERCC1 
Lys226STOP 
IVS6-26GA 
15   +  - [129] 
165TOR  
Glu158STOP 
Phe231Leu 
congenit
al 
15 + (5X) + - - [11] 
1. Age of patient at time of diagnosis and patient’s gender.  2. Unscheduled DNA synthesis as a percentage 
compared to control cells 3. Fold increase in UV sensitivity of patient fibroblasts compared to control cells  4. 
Presence (+) or absence (-) of neurodegenerative symptoms.  5. Presence (+) or absence (-) of abnormal 
pigmentation including freckling, blistering, epidermal atrophy and keratoses.  6. Presence (+) or absence (-) of skin 
carcinomas (basal cell and squamous cell carinomas). Blue region indicates XP-F patients without symptoms of 
neurodegeneration; pink region indicates XP-F patients with symptoms of neurodegeneration; green region indicates 
patients with mutations in ERCC1. 
 
 10 
The first XPF-deficient human patient was reported in 1979, several years before the XPF 
gene was identified and cloned [82].  The patient, referred to as XP23OS, was confirmed as XP-
F by genetic complementation analysis, and exhibited mild XP symptoms including freckling 
and photosensitivity. Primary cells from patient XP23OS have only 10% of the normal level of 
NER as measured by UV-induced unscheduled DNA synthesis (UDS), but only modest 
sensitivity to UV as measured by clonogenic survival. The discrepancy can be explained by the 
fact that UDS measures NER that occurs in the first 3 hours following UV irradiation, whereas in 
a clonogenic survival assay cell growth is measured in the 7-10 days following UV irradiation. 
Thus XP23OS cells must have low levels of NER, but that is adequate to prevent cell death and 
replicative senescence given adequate time to repair the genome [83].  Furthermore, host cell 
reactivation of reporter expression following UV damage was only modestly impaired.  These 
results suggest that although the efficiency of NER was impaired in this patient, the pathway 
must be intact to explain the relatively mild symptoms in this 45 year-old patient.  In the years 
that followed, several patients with XP group F were described, most of them from Japan, having 
mild to moderate symptoms, similar to patient XP23OS [84-89].  The majority of XP-F patients 
had UV sensitivity and freckling of the skin, but severe ocular and neurological symptoms were 
rare in the XP-F complementation group (see Table 1) [90, 91].  It is important to note that there 
have been reports of additional XP-F patients that are not included in Table 2 because the 
mutations have yet to be verified in genomic DNA [92].   
The human XPF gene was cloned in 1996 with the identification of a human gene 
homologous to yeast Rad1 [45, 93].  This cDNA corrected the defect in cells from XP group F 
patients.  Additionally, causative mutations were identified in XP-F patients that corresponded to 
this gene.  Following the cloning of XPF, an unusual XP-F patient was described displaying 
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progressive late-onset neurologic decline [94].  This patient, referred to as XP42RO, had mild 
ocular photophobia with severe erythema on sun exposure.  Basal and squamous cell carcinomas 
were detected in the second decade of life and by the fourth decade the patient exhibited 
profound neurodegenerative symptoms including ataxia, cerebral and cerebellar atrophy.  The 
mutation found in XP42RO cells is a C→T transition at nucleotide 2377, which results in a 
change of the conserved arginine residue at 799 to a tryptophan.  The R799W mutation was 
identified in at least eight other XP-F patients, in six of whom neurodegeneration was reported 
(see Table 1).  Patient XP126LO harbors the R799W mutation but without neurologic symptoms 
to date.  One possible explanation is that neurologic symptoms may not appear until the 4
th
 or 5
th
 
decade of life, and this patient was assessed and diagnosed at 22 years of age.    
More recently, mutations in XPF were linked to a novel progeroid syndrome or disease of 
accelerated aging (called XFE progeroid syndrome). The patient, referred to XP51RO, had 
severe photosensitivity, which led investigators to hypothesize that NER was defective, and 
genetic complementation with XP patient cells revealed that XPF was affected [29].  In addition 
to sun sensitivity and the classical symptoms of XP, patient XFE had severe symptoms of 
accelerated aging that affected the neurologic, hepatobiliary, musculoskeletal, and hematopoietic 
systems.  Mutation analysis revealed a G→C transversion at position 458 which resulted in a 
non-conservative substitution of arginine at residue 153 to proline.  The mutation in XPF was 
unexpected because patient XFE had severe symptoms of accelerated aging unlike most other 
XP-F patients who had mild XP.  R153 is located within a conserved helicase motif of XPF 
which is also a leucine-rich region postulated to be important for protein-protein interactions.  
Primary fibroblasts from patient XP51RO are highly sensitive to UV and the crosslinking agent 
mitomycin C. Patient XP51RO had normal early postnatal development, but progeroid 
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symptoms began to appear in early prepubescence.   The symptoms included an old, wizened 
appearance, loss of subcutaneous fat, liver dysfunction, vision and hearing loss, renal 
insufficiency, muscle wasting , osteopenia, kyphosis and cerebral atrophy.  These symptoms of 
accelerated aging are strikingly similar to those seen in Ercc1
-/-
 and Xpf
m/m
 mice (Figure 17).   
Very recently a patient with features similar to XP51RO was identified in the UK. The 
patient has the facial appearance of CS, sun-sensitivity, microcephaly, neurological problems and 
developmental delay, together with pancytopenia and renal failure. Cellular studies revealed low 
UDS and assignment to the XP-F group (D. Pilz, D.  McGibbon, R. Sarkany, M. Stefanini and A 
Lehmann, personal communication). XP-F patients with early onset and more severe symptoms 
appear to have mutations that lead to mislocalization of ERCC1-XPF to the cytoplasm, thereby 
decreasing the cellular capacity for efficient repair of nuclear DNA [81].   
1.2.2 ERCC1 mutations in humans 
ERCC1 was the first human DNA repair gene cloned [95].  For decades, however, no patients 
were identified with ERCC1 mutations; hence the gene does not have the standard XP 
nomenclature (XP-x) like other NER factors associated with xeroderma pigmentosum.  Recently, 
a single patient was discovered who had mutations in ERCC1 resulting in severe pre- and 
postnatal developmental defects [30].  The patient, referred to as 165TOR, had severe skeletal 
defects at birth, including microcephaly, arthrogryposis and rocker-bottom feet.  These 
abnormalities were seen in conjunction with neurological alterations including cerebellar 
hypoplasia and blunted cortical gyri.   The clinical diagnosis was cerebro-oculo-facio-skeletal 
syndrome, or COFS syndrome. COFS syndrome was first reported by Lowry in 1971, and 
further characterized in the Manitoba aboriginal population by Pena and Shokeir in 1974 [96, 
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97].  COFS syndrome is a rare autosomal recessive disorder in which patients undergo rapid 
neurologic decline.  Symptoms include but are not limited to brain microcephaly and atrophy 
with calcifications, cataracts, optic atrophy, progressive joint contractures, and severe postnatal 
growth failure [98].   Patients with COFS syndrome are reported to have mutations in genes 
encoding DNA repair proteins ERCC6/CSB, ERCC5/XPG and ERCC2/XPD [99, 100].   
Two mutations were found in the coding region of ERCC1 in patient 165TOR.  The 
maternal allele harbors a C→T transition that converts Gln158 into an amber translational stop 
codon.  The result is a truncated polypeptide that lacks the entire C-terminal domain, essential 
for binding XPF [101].  The paternal allele has a C→G transversion, resulting in the conversion 
of Phe231 to leucine.  This amino acid falls within the C-terminal tandem helix-hairpin-helix 
domain of ERCC1, critical for binding XPF, and is conserved in invertebrates and mammals 
[101].  ERCC1 mRNA levels were normal in this patient, although the protein levels of ERCC1 
and XPF in the nucleus were reduced 4-5-fold.  The truncated protein was not detectable by 
immunoblot. Accordingly, fibroblasts from patient 165TOR had 15% of the normal level of 
NER, representing a modest defect, suggesting that the missense mutation affects stability of 
ERCC1-XPF and/or its nuclear localization, but not enzymatic activity.  
Unexpectedly, the expression of ERCC1-XPF in 165TOR cells is reduced but 
comparable to a patient with mild XP-F.  Several hypotheses have been proposed to explain this 
incongruity, the simplest being that ERCC1 and XPF play distinct roles in vivo.  Evidence 
against this hypothesis includes the fact that Ercc1
-/-
 and Xpf
m/m
 mice have apparently identical 
phenotypes [49, 52]. Additionally, ERCC1 and XPF are required to stabilize one another in vivo 
[32, 101].  It is important to note that COFS is also caused by mutations in the TFIIH subunit 
XPD and the NER endonuclease XPG that stabilizes TFIIH [98, 102-104].  ERCC1-XPF and the 
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other members of the NER machinery have been demonstrated to play a role in regulating 
transcription that has been suggested to be independent of their role in DNA repair [105]. 
Therefore, the clinical severity of patient 165TOR may be due to a transcriptional transcription-
coupled nucleotide excision repair defect during development. It is also possible that 165TOR 
was genetically replete of functional ERCC1-XPF during development, but selective pressure led 
to partial reversion of the cellular phenotype postnatally. Reversion with mosaicism has been 
reported in many genome instability disorders including Fanconi anemia, Werner and Bloom 
syndromes, and observed for ERCC1-XPF deficient cells chronically exposed to crosslinking 
agents [60, 106-108].  In addition, there are undoubtedly modifier genes that affect the severity 
of symptoms caused by mutations in ERCC1 or XPF as illustrated by the fact that Ercc1
-/-
 mice 
are not viable in inbred C57Bl/6 or FVB/n inbred backgrounds but are born with Mendelian 
frequency in an f1 mixed background [29].  Finally, little is known about regulation of ERCC1-
XPF expression, which could be tissue-specific and therefore contribute to heterogeneous 
phenotypes. Identifying modifier genes, identifying regulators of nuclease expression and 
modeling additional patient mutations in mice will be essential for deciphering 
genotype:phenotype correlations. A second patient with mutations in ERCC1 was briefly 
described recently [129].  The patient had a nonsense mutation affect amino acid 226, which lies 
early in the helix-hairpin-helix domain necessary for binding XPF. The second allele contains a 
splicing mutation (IVS6-G→A). The patient displayed neurologic symptoms beginning at age 15 
years and died by the age of 37. Neurodegeneration was progressive and severe resulting in 
dementia and cortical atrophy. The symptoms are very similar to XPF patients with neurologic 
involvement (Table 1) supporting the conclusion that ERCC1 and XPF function exclusively as a 
complex in vivo. 
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1.3 MOUSE MODELS OF ERCC1-XPF DEFICIENCY 
1.3.1 ERCC1 knockout mice 
To understand the biological significance of ERCC1, the gene was knocked-out in the mouse by 
two independent laboratories [43, 49].  The two knockout alleles were created by interrupting 
different exons.  McWhir et al created the first knockout mouse model by disrupting exon 5 of 
Ercc1 leading to a truncated transcript missing the last four exons, which contain the XPF 
interaction domain [32, 36, 49]. The second knockout strain was generated by inserting a 
neomycin resistance cassette into exon 7 of Ercc1 [43].   The result was a truncation in the helix-
hairpin-helix motif required for interaction with XPF [101].  Ercc1 mRNA was not detected in 
these mice [43].  The former strain is born with Mendelian frequency; the latter is sub-
Mendelian, likely due to differences in the genetic background [43, 49]. Deletion of ERCC1 is 
lethal in a fully inbred genetic background, indicating that there are modifier genes that influence 
the severity of the phenotype [29]. In both knockout strains, postnatal growth is severely retarded 
and the mice die at approximately 3 weeks of age when they weigh only about 20% compared to 
their normal littermates [43, 49]. The median lifespan of Ercc1
-/-
 mice in an f1 mixed genetic 
background of 50:50 C57BL/6:FVB/n is 21 days and the maximum lifespan 28 days [29]. The 
Ercc1
-/-
 mice spontaneously develop symptoms characteristic of progressive neurodegeneration, 
including dystonia, trembling and ataxia [29]. 
The hematopoietic system of Ercc1
-/-
 mice develops normally [109].  However, by the 
end of life, Ercc1
-/-
 mice are leukopenic and thrombocytopenic, and there is extensive adipose 
transformation of the bone marrow, hallmark features of normal aging in mice [109].  
Proliferation of multi-potent and lineage-committed progenitors from Ercc1
-/-
 mice is profoundly 
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impaired [109]. Collectively, these data suggest that ERCC1-deficient mice undergo rapid 
turnover of hematopoietic cells leading to premature exhaustion of stem cell reserves.  In 
addition, bone marrow progenitors from Ercc1
-/-
 mice are exquisitely sensitive to crosslinking 
agents, similar to murine models of Fanconi anemia [109, 110] .  
The liver of Ercc1
-/-
 mice is prominently affected, with hepatocellular polyploidy, 
aneuploidy and G2 arrest [49, 111, 112]. The structural changes correlate with impaired liver 
function as demonstrated by significantly increased liver enzymes in the serum [49]. Ercc1
-/-
 
mice develop kyphosis, sarcopenia, dystonia and ataxia, indicative of musculoskeletal and 
nervous system defects [29]. There is a suppression of the somatotroph, lactotroph and 
thyrotroph hormonal axes in the Ercc1
-/-
 mice, which explains their growth delay and diminutive 
size [29].  Many of the degenerative and endocrine abnormalities are similar to what occurs with 
old age in mice [113, 114].  To further investigate the relationship of DNA repair deficiency to 
normal aging, genome-wide expression changes in Ercc1
-/-
 mice relative to wild-type littermates 
was compared to changes that occur with natural aging (differences in gene expression between 
old wild-type and young wild-type mice). There is a highly significant overlap between these 
two profiles whether comparing gene-by-gene or by comparing over-represented biological 
pathways [29]. This provided some of the early support for the notion that DNA damage may 
contribute to aging. 
1.3.2 XPF mutant mice 
Tian et al recreated the XPF mutation in patient XP23OS in the mouse [52].   The patient had a 
single base insertion after nucleotide 1330 leading to a frameshift mutation after Lysine 455 and 
a stop codon 38 residues later [92].  This leads to truncation of XPF upstream of the catalytic 
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domain and its ERCC1-interaction domain [36]. The clinical phenotype of the patient was mild, 
having reached her 4
th
 decade without neurodegeneration or skin cancer [92]. In keeping with 
this, the level and length of the XPF transcript in XP23OS cells are comparable to normal cells, 
illustrating that the patient must have a 2
nd
 XPF allele.  To further emphasize this, a mouse 
homozygous for the frameshift mutation has undetectable levels of Xpf mRNA and a severe 
phenotype identical to that of ERCC1 null mice [52].   The Xpf
m/m
 mice develop normally and are 
born with Mendelian frequency. However, postnatal growth is delayed such that by 2 wks of age 
the Xpf
m/m
 mice are approximately 25% the size of littermates, and die by 3 wks of age. 
Hepatocellular polyploidy was prominent, as in the Ercc1
-/-
 mice [52]. The phenotypic parallels 
between ERCC1 and XPF null mice strongly suggest that the proteins function exclusively as a 
complex. 
Importantly, ERCC1 and XPF-deficient mice appear to have a normal complement of 
mature and immature B cells [52, 115, 116]. This provides definitive evidence that ERCC1-XPF 
is not essential for NHEJ, the DSB repair pathway required for class switch recombination 
(CSR) [117]. However, ex vivo CSR is mildly attenuated in splenocytes isolated from Ercc1
-/-
 
mice and the mutation pattern in the switch region of the immunoglobulin locus is significantly 
different from that of normal littermate mice, suggesting that ERCC1-XPF may contribute to 
DNA end-processing of DSBs at the Ig locus [116]. Consistent with this, ERCC1-deficient mice 
are hypersensitive to IR, which induces DNA DSBs [22]. 
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1.3.3 Liver corrected Ercc1-/- mice 
To investigate the cause of death in Ercc1
-/-
 mice, Selfridge et al crossed the mice with a 
transgenic strain expressing ERCC1 specifically in the liver, using transthyretin (TTR) 
regulatory sequences to control ERCC1 expression [118]. The resulting mice (Ercc1
-/-
 + TG) 
have dramatically improved growth, reaching 58% of normal body weight for their age. 
Furthermore, their lifespan is significantly increased, with a median survival of ~75 days. 
Hepatocellular polyploidy and abnormal liver functions are largely corrected by expression of 
ERCC1 in the liver. Interestingly, by 7 wks of age, the transgenic mice begin to display evidence 
of renal dysfunction (significantly elevated serum creatinine and proteinuria) and renal 
histopathology (glomerulosclerosis, hyaline casts, renal tubular epithelial anisokaryosis, 
karyomegaly, hyperchormasia, pyknosis and keryorrhexis) [118, 119]. These data suggest that 
Ercc1
-/-
 mice die of liver failure and that hepatocytes and renal cells are the most vulnerable to 
loss of ERCC1-XPF-dependent DNA repair. 
Since the Ercc1
-/-
 + TG mice live longer than Ercc1
-/-
 mice, they are a practical system 
for identifying other tissues affected by ERCC1-deficiency.  Performance of Ercc1
-/-
 + TG mice 
on an opto-kinetic response test to measure visual acuity is impaired by 4 wks and worsens with 
age [119]. Structural abnormalities of the eye were not detected, indicating that loss of vision is 
not due to a developmental defect [119]. Also, there is no evidence for retinal degeneration 
typical of CSB mice, another NER-defective mutant strain [120].  
Like Ercc1
-/-
, symptoms associated with neurodegeneration were observed in Ercc1
-/-
 + 
TG mice. The Ercc1
-/-
 + TG mice displayed dystonia and ataxia indicative of a cerebellar defect. 
While mild atrophy of the neocortex and cerebellum were observed, there were no abnormalities 
or loss of Purkinje cells to explain these phenotypes. Also, there were no signs of degeneration at 
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the neuromuscular junctions. Therefore these symptoms were attributed to uraemic 
encephalopathy, caused by kidney failure [119].  
Male and female Ercc1
-/-
 + TG mice were found to be infertile [121]. Testes of these 
mice were approximately 50% the normal size at puberty and contained significantly less 
spermatocytes. Spermatogenesis is not arrested at a particular stage, as expected for a meiotic 
defect, but instead there is abundant apoptosis in these rapidly dividing cells [121, 122]. This 
leads to a resulting 97% reduction in the sperm count [122]. Ovaries from adult Ercc1
-/-
 + TG 
mice showed a reduced number of oocytes and an absence of primary follicles [121]. 
1.3.4 ERCC1 mutant mice 
To further probe the DNA repair function of ERCC1 in vivo, a premature stop codon was 
engineered at position 292 of mErcc1 [43].   This results in a C-terminal deletion of 7 amino 
acids of the murine protein, including a phenylalanine residue at position 293, thought to be 
essential for binding to XPF [101]. Thus the prediction was that this mutation would ablate DNA 
repair function without compromising the protein stability [32]. Unlike either of the null alleles, 
normal levels of the mutant Ercc1 transcript are detected in the tissues from the mutant mice 
[43]. Homozygous Ercc1
*292
 (also referred to as Ercc1
Δ/Δ
) mice live up to 6 months, which is 6X 
longer than ERCC1 null mice. Similar to the Ercc1
-/-
 mice, the Ercc1
*292
 mice are infertile and 
their skin is atrophic and lacks subcutaneous fat [43].  The spleen of Ercc1
*292
 mice contains 
increased ferritin and hemosiderin deposits, indicative of a high turnover of erythrocytes. The 
kidney exhibits dilated renal tubules with hyaline casts. Nuclear polyploidy is common in the 
liver and kidney.  Thus virtually all of the phenotypes of Ercc1
-/- 
mice are recapitulated in this 
longer-lived mutant strain. Primary mouse embryonic fibroblasts (MEFs) from the Ercc1
-/- 
mice 
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are modestly more sensitive to the crosslinking agent mitomycin C than MEFs from Ercc1
*292
 
mice, suggesting that their increased longevity is due to increased DNA repair capacity [43]. 
Despite this, topical application of the tumor initiator DMBA to Ercc1
*292
 mice, leads to acute 
toxicity rather than carcinogenesis, illustrating a dramatic difference from other NER-deficient 
mice [43]. 
1.3.5 ERCC1 hypomorphic mice 
Combination of one null and one mutant Ercc1 allele yields mice (Ercc1
-/*292
; Ercc1
-/Δ
 or 
Ercc1
d/-
) that are born with Mendelian frequency and have an even greater maximal lifespan of 7 
months in an f1 background of 50:50 C57Bl/6J:FVB/n [123]. Ercc1
-/Δ
 mice are runted compared 
to their wild-type littermates [124]. However, they develop normally until sexual maturity, at 
which point they began to exhibit signs of rapid aging [125]. They live 24-30 weeks while 
progressively developing dystonia, tremors, kyphosis and ataxia [124]. 
The Ercc1
-/Δ
 mice were crossed with a transgenic lacZ reporter strain to measure the 
mutation frequency in vivo [123]. The mutation frequency is modestly elevated in the liver of 5-6 
month old Ercc1
-/Δ
 mice compared to normal littermates. Interestingly, the mutations are 
primarily chromosomal rearrangements characteristic of old wild-type mice rather than point 
mutations characteristic of NER-deficient mice [123]. This observation extends the parallels 
between the progeroid Ercc1
-/Δ
 mice and aged normal mice. 
Ercc1
-/Δ
 mice are hypersensitive to IR [22]. Even though these mice are hypomorphic for 
ERCC1-XPF, they were equally as sensitive to IR as DNA-PKcs knockout mice [126].  IR 
causes persistent γ-H2AX foci in ERCC1-deficient cells and mice, supporting a role for ERCC1-
XPF in the repair of DSBs. The involvement of ERCC1-XPF in DSB repair is presumably a Ku-
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independent pathway since Ercc1
-/- 
Ku86
-/-
 mice are not viable [22].  Ercc1
-/-
 MEFs have normal 
levels of spontaneous and mitomycin C-induced sister chromatid exchanges, illustrating that 
ERCC1-XPF is not essential for homologous recombination [75, 127]. In contrast, DSBs with 3’ 
overhangs cause large deletions in Ercc1
-/-
 cells [22, 75]. These genetic and in vitro data support 
a role for ERCC1-XPF in processing a subset of DSBs (those with 3’ overhangs) and a role in 
the alternative end-joining pathway of DSB repair [128]. 
Ercc1
-/-
, Ercc1
-/-
 + TG, and Ercc1
-/Δ
 mice all develop progressive dystonia, tremors and 
ataxia, highly suggestive of neurodegeneration [29, 119, 124]. The former strains display 
cerebellar hypoplasia, similar to the ERCC1 patient 165TOR, but this could not be completely 
dissected from developmental abnormalities, due to their young age [29, 30, 119]. Evidence for 
degenerative processes in the central nervous system is quite clear in Ercc1
-/Δ
 mice [124]. De 
Waard et al found profound astrocytosis and microgliosis in the spinal cord of 4 month old 
Ercc1
-/Δ
 mice, compared to normal littermates and 1 month old mutant animals.  This is 
accompanied by a significant reduction in the number of motor neurons in the ventral horn of the 
spinal cord and a concomitant denervation of the skeletal muscle. There is an approximately 50% 
reduction in neurons from 4-8 wks of life, and then again from 8-16 wks of life in the Ercc1
-/Δ
 
mice. It is also evident that the pre-synaptic motor nerve terminals have degenerated in the aged 
Ercc1
-/Δ
 mice with characteristics similar to those seen in amyotrophic lateral sclerosis and aging 
motor neurons [124]. 
Genome-wide expression profiling of Ercc1
-/Δ
 mice revealed a highly significant 
correlation with the transcriptome of numerous long-lived models, including Ames and Snell 
dwarf mice and/or calorically restricted mice [113]. In addition, there is a significant correlation 
with the transcriptome of old wild-type mice. This indicates that Ercc1
-/Δ
 mice look biologically 
 22 
“old”, but also that the failure to repair DNA damage in these mice triggers activation of a stress 
response that is transcriptionally regulated and promotes longevity. Schumacher et al showed 
that this same stress response is also triggered by nutritional deprivation and is mediated through 
suppression of GH-IGF1 signaling as evidenced by the significant correlation with Ames and 
Snell dwarf mice.  All of these mice displayed suppression of the somatotroph axis, oxidative 
metabolism and peroxisomal biogenesis coupled with an upregulation of antioxidants, DNA 
damage and apoptosis [113].   
This was further supported by analysis of metabolites in the serum and urine of Ercc1
-/Δ
 
mice [125]. There is no difference between Ercc1
-/Δ
 mice and normal littermates at 8 and 12 
weeks of age.  However by 16 weeks, there are significant differences, which become further 
amplified by 20 weeks of age. Collectively, these data support the conclusion that Ercc1
-/Δ
 mice 
develop normally into adulthood, but then undergo degenerative changes.  Several of the 
metabolic changes mimic those that occur with caloric restriction, including increased HDL, 
decreased LDL and VLDL, and ketosis. However, a number of metabolic changes in the Ercc1
-/Δ
 
mice are also consistent with degeneration, such as increased glucose, citrate and succinate in the 
urine indicative of kidney dysfunction, and metabolic alkalosis indicative of liver dysfunction 
[125]. These observations are consistent with the model that DNA damage accumulates in Ercc1
-
/Δ
 mice leading to metabolic reprogramming in response to stress [113]. This may be beneficial, 
but in the long-run is insufficient to sustain the organism in the face of continued DNA damage 
[29]. 
Remarkably, Ercc1
-/Δ
 mice spontaneously develop numerous diseases associated with old 
age in humans (Table 3). This includes osteoporosis and intervertebral disc degeneration [129]. 
There is progressive attrition of disc extracellular proteoglycans with age, leading to loss of disc 
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height and its cushioning function [130, 131]. Similar changes were observed in discs of 5 month 
old Ercc1
-/Δ
 mice and exacerbated in mice treated with genotoxic chemotherapeutic agents [129]. 
These observations support the conclusion that DNA damage, if not repaired, can promote 
common aging-related degenerative diseases, even in post-mitotic tissues. 
 
. 
 
          Ercc1
-/-
     Ercc1
-/Δ
         XFE    Human aging   Ref. 
Maximum Lifespan 4 weeks 28 weeks 16 years 120 years [76] 
Loss of subcutaneous  
fat 
 
+ 
 
+ 
 
+ 
 
+ 
 
[100] 
Atrophic epidermis + + + + [99] 
Hearing loss + + + + [76] 
Visual impairment + + + + [76] 
Tremors + + + + [101] 
Ataxia + + + + [101] 
Cerebral atrophy + + + + [102] 
Hypertension ? ? + + [76] 
Renal acidosis + + + + [103] 
Bone marrow 
degeneration 
 
+ 
 
+ 
 
+ 
 
+ 
 
[100] 
Osteoporosis + + + + [76] 
Kyphosis + + + + [102] 
Dystonia  
+ 
 
+ 
 
+ 
 
- 
[10, 
86] 
Sarcopenia + + + + [76] 
Frailty + + + + [76] 
Urinary Incontinence ? + + + [76] 
Disc degeneration + + ? + [104] 
Table 3. DNA repair deficiency parallels natural aging 
Symptoms observed in Ercc1-/- mice, Ercc1-/∆ mice, and patient XP51RO who had a progeroid syndrome 
(or disease of accelerated aging) due to a homozygous mutation in XPF, and which the ERCC1 mice model. Also 
indicated are whether or not the same symptoms associated with old age in humans of human aging and (+) or (-) 
indicates presence or absence in the Ercc1-/- mice, Ercc1-/∆ mice, or progeroid patient XP51RO. 
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1.3.6 Tissue specific deletion of ERCC1 
Tissue-specific deletion of a gene is a powerful tool for dissecting a complex phenotype, such as 
that of the ERCC1-deficient mice, allowing for dissection of whether a particular symptom or 
pathology is a direct consequence of a deletion of a gene or merely a secondary consequence 
(e.g., is neurodegeneration due to loss of ERCC1 in neurons or uraemic encephalopathy due to 
loss of ERCC1 in the kidneys?). Tissue specific knockout of protein expression occurs if the 
gene of interest (or an exon vital to its function) is flanked (floxed) by recombination signals 
(loxP or FRT) and mice expressing the two copies of the floxed allele are crossed with transgenic 
mice expressing recombinase (CRE or FLP, respectively) under a tissue specific promoter [132]. 
Another important attribute of this approach is that it is possible to distinguish developmental 
from degenerative changes by selecting promoters that are active only postnatally.   
A floxed allele of Ercc1 was generated by inserting loxP sites in intron 2 and 5, such that 
Cre recombinase excises exons 3-5 of the Ercc1 locus [133]. Mice harboring two floxed alleles 
of Ercc1 were crossed with transgenic mice expressing Cre-recombinase under a tyrosinase 
promoter [134]. The goal was to knockout expression of ERCC1 in melanocytes to generate a 
murine melanoma model.  Unexpectedly, the mice die by 6 months of age due to severe colonic 
obstruction. Tyrosinase is expressed in all neural crest cell-derived lineages, including 
parasympathetic neurons that innervate the gastrointestinal tract and are required for colonic 
peristalsis.  Knocking-out ERCC1 expression in neural crest cells causes p53 activation and 
apoptosis of ganglion cells in the mesenteric plexus. Denervation of the bowel explains the 
colonic obstruction and demonstrates that ERCC1-XPF dependent DNA repair is critical for 
protecting neurons from degeneration [134]. This provides strong evidence that the neurological 
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symptoms observed in ERCC1-deficient mice are due, at least in part, to loss of functional 
neurons rather than a defect in supportive glial cells. 
ERCC1 was also knocked-out specifically in the skin to create a model of UV-induced 
skin cancer. Ercc1
flox/-
 mice were crossed with transgenic mice expressing Cre recombinase 
under the keratin 5 (K5) promoter, which is only expressed in the basal layer of the epidermis 
[133]. To facilitate UV carcinogenesis studies, these mice were produced in an albino, hairless 
background. Deletion of Ercc1 in the skin leads to a 20-fold reduction in the minimal erythemal 
dose in response to UV-B irradiation, leading to dramatic, but transient hyperplasia [133]. 
Furthermore the mice develop significantly more skin tumors, early, and at a lower dose of UVB 
than normal controls. The cumulative dose of UV-B required to induce tumors in half of the 
ERCC1-deficient mice was 37X lower than normal controls in a chronic exposure study [133]. 
The mice also developed actinic keratosis and squamous cell carcinomas. Thus this tissue-
specific knockout strain offers an accurate and rapid (tumors within 8 weeks) model of UV-
induced skin cancer, which may be useful in the study of XP. Subsequently, these mice have 
been used to test topical treatments that protect against UV-induced skin cancer [135].  
1.3.7 Double mutant mice 
TRF1 and TRF2 are sheltrin proteins required to protect telomeres at chromosomal ends [136].  
Overexpression of either protein leads to a dominant negative effect exemplified by telomere 
shortening, loss of telomeric 3’ G-rich overhangs and end fusions [28, 137]. Overexpression of 
TRF2 in the skin of mice by putting the cDNA under control of the keratin 5 promoter 
(K5TRF2), leads to skin atrophy, hyperpigmentation and increased skin cancer in sun-exposed 
areas. These results demonstrate that dysregulation of telomeres promotes UV-induced skin 
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cancer [28]. Skin and keratinocytes isolated from either K5TRF1 or K5TRF2 mice contain 
telomeric defects, which were rescued by knocking-out Xpf [28, 137]. This strongly supports the 
previous observation that the absence of ERCC1-XPF does not negatively impact telomere 
length or function, but instead has an unexpected beneficial effect [27]. 
1.4 SUMMARY 
There is tremendous variability between patients with mutations in ERCC1 or XPF, 
ranging from mild cutaneous symptoms to severe neurodegeneration. ERCC1 patient 165TOR 
had severe developmental abnormalities that are not normally seen in XP-F patients. These 
differences cannot be fully predicted by the patients’ mutations or the level of residual NER 
(UDS) in patient fibroblasts. Clearly, further work is needed to decipher how expression and 
activity of ERCC1-XPF is regulated. This in turn is likely to yield better methods for predicting 
the physiological consequences of a particular mutation [138]. The studies in mice have been 
crucial for a number of reasons. First, the identical phenotypes of Ercc1
-/-
 and Xpf
m/m
 mice, which 
are null for XPF, provide the strongest possible evidence that ERCC1 and XPF must function 
exclusively as a heterodimer. Second, the unexpected premature aging phenotypes of the ERCC1 
mutant mice led to the discovery of a new rare genetic disease (XFE progeroid syndrome) and 
contributed to the body of evidence that DNA damage is one type of cellular damage that 
promotes aging-related degenerative changes (e.g., neurodegeneration). Third, it is clear that the 
severity of symptoms, associated with ERCC1-XPF deficiency, are somehow linked to variable 
levels of expression or activity. This implies that functional single nucleotide polymorphisms in 
either gene may be important for predicting risk of cancer or degenerative diseases.  Fourth, 
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Ercc1 mutant mice are unique amongst the NER-deficient mutant strains because they 
spontaneously develop neurodegeneration, which may be used to screen therapies for treating 
XP, CS and TTD patients. Finally, tissue-specific ERCC1 knockout strains will be crucial for 
identifying which tissues and cell types are most vulnerable to DNA damage and are responsible 
for triggering systemic stress responses.  
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2.0  THE LIVER RESPONSE TO ENDOGENOUS DNA DAMAGE 
Chapter 2 is adapted, with copyright permission, from John Wiley and Sons, from a published 
article in Hepatology.  Gregg, SQ, Gutierrez, V, Robinson, AR, Woodell, T, Nakao, A, Ross, 
MA, Michalopoulos, GK, Rigatti, L, Rothermel, CE, Kamileri, I, Garinis, G, Stolz, DB, and 
Niedernhofer LJ.  (2011) A mouse model of accelerated liver aging due to a defect in DNA 
repair.  Hepatology [epub ahead of print] Please note figure numbers have changed. 
 
The liver changes with age leading to an impaired ability to respond to hepatic insults and 
increased incidence of liver disease in the elderly. Therefore, there is critical need for rapid 
model systems to study aging-related liver changes.  One potential opportunity is murine models 
of human progerias, or diseases of accelerated aging.  Ercc1
-/
 mice model a rare human 
progeroid syndrome caused by inherited defects in DNA repair. To determine if hepatic changes 
that occur with normal aging occur prematurely in Ercc1
-/
 mice, we systematically compared 
liver from 5 month-old, progeroid Ercc1
-/Δ
 mice to old (24-36 month) wild-type (WT) mice.  
Both displayed areas of necrosis, foci of hepatocellular degeneration and acute inflammation.  
Loss of hepatic architecture, fibrosis, steatosis, pseudocapillarization, and anisokaryosis were 
more dramatic in Ercc1
-/Δ
 mice than in old WT mice.  Liver enzymes were significantly elevated 
in serum of Ercc1
-/Δ
 mice and old WT mice, while albumin was reduced, demonstrating liver 
damage and dysfunction.  The regenerative capacity of Ercc1
-/Δ
 liver following partial 
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hepatectomy was significantly reduced. There was evidence of increased oxidative damage in 
Ercc1
-/Δ
 and old WT liver, including lipofuscin, lipid hydroperoxides and acrolein as well as 
increased hepatocellular senescence. There was a highly significant correlation in genome-wide 
transcriptional changes between old WT and 16 but not 5 week-old Ercc1
-/
 mice emphasizing 
that the Ercc1
-/
 mice acquire an aging profile in early adulthood. Conclusion: There are strong 
functional, regulatory and histopathological parallels between accelerated aging driven by a 
DNA repair defect and normal aging. This supports a role for DNA damage in driving aging and 
validates a murine model for rapidly testing hypotheses about causes and treatment for aging-
related hepatic changes.  
2.1 INTRODUCTION 
Aging is characterized by the progressive loss of homeostatic reserve in all tissues leading to a 
decreased ability to respond to stress, functional decline and dramatically increased risk of 
morbidity and mortality[12].   Chronic liver disease and cirrhosis are the twelfth leading cause of 
death in the United States, with 25,192 (1.1%) deaths each year[139].  Mortality due to liver 
disease is not limited to the United States, as the World Health Organization (WHO) estimates 
that 20 million individuals have cirrhosis and/or liver cancer worldwide, and that 1-2 million die 
annually as a result of liver failure.  Many liver diseases are more prevalent in the elderly, 
including alcohol-induced cirrhosis, viral hepatitis-induced cirrhosis, diabetic-associated chronic 
liver disease, hepatocellular carcinoma and biliary cirrhosis[140, 141], illustrating that aged liver 
is less able to cope with a variety of stressors. 
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Although there are no definitive biomarkers of aged liver, there are several hallmark 
structural changes.   The volume of the liver decreases with age[142]. This decrease is gender-
specific, with an average decrease of 6.5% in males and 14.3% in females[143].  Hepatocytes are 
quiescent cells, until stimulated to proliferate following injury or surgical resection[144].  The 
capacity for hepatocyte regeneration following partial hepatectomy decreases with age[145].  
During the aging process, the nuclear size and shape of hepatocytes becomes altered[112].   
Nuclear invaginations and larger nuclei are commonly associated with age in liver samples[146].  
Nuclear polyploidy of hepatocytes increases with age, rising from 7-10% in young mice to 
approximately 30% in old mice[112].  Finally, lipofuscin, insoluble oxidized proteins, 
accumulates in the cytoplasm of hepatocytes[147, 148]. 
Liver sinusoidal endothelial cells (LSEC) line the hepatic microvasculature, express little 
to no basement membrane, and exhibit numerous fenestrations necessary for filtering lipopoteins 
from the portal blood supply.  A reduction in the number of these pores combined with the 
thickening of the endothelium, called pseudocapillarization, is commonly seen in aged 
livers[149], as is non-alcoholic fatty liver disease or steatosis[150].   The underlying cause for 
fatty liver disease is not known, but some possibilities include diabetes mellitus, oxidative stress, 
mitochondrial dysfunction and metabolic and hormonal imbalances[151].  All of these age-
related liver changes in humans are recapitulated in the mouse[152-156]. 
Aging research is challenging because of the incredible variability in humans. Mice offer 
an attractive alternative because genetic and environmental variables can be controlled. 
Nevertheless, the time and expense required to generate and maintain mice >3 years of age is 
daunting.  One approach to overcome this is to use mouse models of accelerated aging, or human 
progerias. Werner syndrome, Cockayne syndrome, XFE progeroid syndrome and 
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trichothiodystrophy are examples of human diseases of accelerated aging[157].  A common 
thread linking these disorders is that they all result from mutations in genes that are involved in 
genome maintenance.  These observations strongly suggest that DNA damage can promote age-
related degenerative changes.   
ERCC1-XPF is a structure-specific endonuclease involved in the repair of several types 
of DNA lesions including interstrand crosslinks, double-strand breaks, and bulky, helix-
distorting lesions[22, 48].   ERCC1 and XPF are obligate binding partners and stabilize one 
another in vivo[29].  Mutations in XPF that cause reduced expression of ERCC1-XPF cause a 
progeroid syndrome characterized by dramatically accelerated aging of most organ systems[29].  
Ercc1
-/-
 and Xpf
-/-
 mice have an identical phenotype to one another and mimic the human 
progeroid syndrome[49, 52].  These mice die in the 4
th
 week of life with aging-like degenerative 
changes, including osteoporosis, neurodegeneration, bone marrow hypoplasia, epidermal 
atrophy, sarcopenia, and liver and kidney dysfunction[29, 109]. Liver dysfunction is life-limiting 
in Ercc1
-/-
 mice[118].  Mice with reduced but not ablated ERCC1-XPF expression live longer 
than Ercc1
-/-
 mice (30 weeks vs. 4 weeks maxiumum lifespan)[124, 158] The Ercc1
-/Δ
 mice are 
healthy into adulthood (8 weeks) then begin to show numerous progressive symptoms associated 
with aging[158].  The aim of  this study was to systematically compare the liver of  4-5 month-
old Ercc1
-/Δ
 mice to that of old WT mice (2+ yrs old) to determine if the progeroid mice offer an 
accurate model of natural aging that could be used to accelerate research on the biology of aging-
related liver changes and therapeutic interventions to extend healthspan
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2.2 MATERIALS AND METHODS 
Animal Care and Experimentation 
Experiments involving mice were approved by the University of Pittsburgh Institutional Animal 
Care and Use Committee and in accordance with the NIH guidelines for humane care of animals.  
Ercc1
-/Δ
 mice were bred and genotyped as previously described[22].  All mice used in this study 
were in an f1 mixed genetic background (FVB/n:C57Bl/6). 
Histological analyses 
6-7 and 20-24 week old WT and Ercc1
-/
 mice, along with aged (26-36 month) WT mice were 
sacrificed by CO2 inhalation, and excised livers were fixed with 10% formalin and embedded in 
paraffin. Tissue sections (6m) were cut and stained with hematoxylin and eosin (H&E) to detect 
changes in liver architecture and Masson’s trichrome to detect fibrosis, using standard 
procedures.  Alternatively liver specimens were cryopreserved by fixation in 10% formalin for 2-
4 hours, followed by incubation in 30% sucrose at 4°C overnight.  Tissues were embedded in 
OCT and flash frozen prior to sectioning on a Microm cryostat.   
Liver Perfusion and Processing for Ultrastructural Analysis 
For scanning and transmission electron microscopy, the liver of euthanized animals was cleared 
of blood by perfusion with phosphate-buffered saline (PBS) at 3mL/min through the inferior 
vena cava as previously described[159].  Samples of liver were fixed with glutaraldehyde and 
processed also as described previously[160].  TEM images were captured with the JEOL JEM 
1011 microscope and SEM images were taken with the JEOL JSM 6330F microscope (JEOL 
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Ltd, Peabody, MA). Porosity was determined using MetaMorph imaging software.  Fenestrations 
were manually predetermined and porosity expressed as percent of measured total sinusoid area. 
Immunofluorescence Analyses 
Staining for acrolein was performed on deparaffinized liver sections from 20 wk-old WT, Ercc1
-
/Δ 
mice and aged (24-36 mth-old) WT mice. Paraffin embedded tissue sections were subjected to 
heat induced-epitope retrieval by incubation in sodium citrate buffer (10mM, pH 6.0) for 10 min 
in a microwave, followed by 30 min cool-down. Sections were permeabilized with PBS-Tween 
(0.05%) and incubated with rabbit polyclonal to acrolein (1:500, ab37110, Abcam, Cambridge, 
MA), CD31 (1:500, 550274, BD Pharmingen, San Diego, CA), F4/80 (1:500, 552958, BD 
Pharmingen, San Diego, CA), α-SMA (1:500, #6198, Sigma, St. Louis, MO), and Desmin 
(1:250, ab15200, Abcam, Cambridge, MA) overnight at 4°C.  The secondary antibody, Alexa 
Fluor 594 goat anti-rabbit IgG (1:1000, A11012, Molecular Probes, Eugene, OR), was allowed to 
incubate for 60 min in the dark.  Nuclei were stained with Vectashield with DAPI mounting 
medium (Vector Laboratories, Inc., Burlingame, CA). Ten random images per sample were 
acquired using an Olympus BX51 fluorescent microscope. Acrolein fluorescence intensity was 
quantified using the Axio Vision imaging software (Carl Zeiss, Gottingen, Germany).  Average 
fluorescence intensity is shown ± S.E.M. All p-values reported were derived using a standard 
Student’s t test with a two-tailed distribution.  Differences were considered significant at the 
95% confidence interval (p < 0.05).   
Immunohistochemical analyses 
Immunohistochemistry for Ki67 (rat anti-mouse Ki67 (TEC-3), Dako Cytomation, Carpinteria, 
CA) was performed on deparaffinized liver sections from 10 wk-old WT and Ercc1
-/Δ 
mice that 
had undergone partial hepatectomy surgery.  Endogenous peroxidase activity was blocked with 
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3% hydrogen peroxide.  Tissue sections were subjected to heat induced-epitope retrieval by 
incubation in sodium citrate buffer (10mM, pH 6.0) for 30 min in a decloaker, followed by 30 
min cool-down. Blocking was done with 5% rabbit serum for 20 min.  Primary antibody was 
applied for 1 hour.  Secondary antibody was applied for 30 minutes, followed by the label 
antibody (ABC Elite, Vector Laboratories, Burlingame, CA) for 30 min.  DAB chromagen 
(Dako Cytomation, Carpinteria, CA) was applied for 6 min, followed by 2 rinse steps in distilled 
water.  Hematoxylin was used as a counterstain.  Brightfield images were collected using an 
Olympus BX51 fluorescent microscope, and Ki67 positive cells were quantified from 5 random 
fields of view from each of 4 mice per group.  Mean percentages were plotted ± S.E.M.; asterisk 
indicates p<0.05 as calculated with the Student’s t test with a two-tailed distribution. 
Detection of Lipids 
Slides with frozen liver tissue were warmed to room temperature, fixed in 2% PFA for 10 min, 
rinsed with PBS, and incubated with LipidTox Red Neutral Lipid Stain (Invitrogen, Foster City, 
CA) for 30 min at room temperature.  Tissues were rinsed in PBS and nuclei were counterstained 
with Hoechst dye for 1 min.  Hoechst dye was rinsed off with 3 PBS washes and tissue was 
covered using gelvatol mounting medium.  Image acquisition was done on an Olympus BX51 
fluorescent microscope.   
Detection of Lipofuscin 
Intracellular lipofuscin was observed by fluorescence microscopy.  6μM liver cryosections were 
fixed in 4% PFA for 10 min, rinsed with PBS and the nuclei stained with Vectashield and DAPI 
mounting medium (Vector Laboratories, Inc., Burlingame, CA).  Green autofluorescent granules 
were detected at an excitation wavelength of 488 nm. Five random images per mouse (n=5 
animals per age group) were acquired using an Olympus BX51 fluorescent microscope. For 
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quantification, the lipofuscin fluorescence intensity was analyzed using the AxioVision imaging 
software (Carl Zeiss, Gottingen, Germany).  All data shown are mean ± S.E.M. P-values were 
calculated using a standard Student’s t test with a two-tailed distribution.  
Lipid peroxidation measurement 
Lipid hydroperoxides were measured in fresh tissue homogenates using the Hydroperoxide 
Assay kit (#705003, Cayman Chemicals, Ann Arbor, MI) according to the manufacturer’s 
instructions. Liver specimens were sonicated on ice in 1 ml of HPLC-grade water and used 
immediately after collection. 
Partial Hepatectomy 
One-third partial hepatectomy (PHx) was performed as previously described[161].  Mice were 
anesthetized using ketamine/xylazine, and a midline incision was made so that the median lobe 
of the liver could be excised.  A knot was tied above the excised lobe, and double-layered sutures 
were used to close the wound.  Mice were warmed and monitored hourly for 12 hours post-PHx.  
Mice were sacrificed 48 hours post-PHx, and tissues were preserved in 2% PFA and frozen in 2-
methylbutane for immunohistochemistry.  
Liver Function Analyses 
Blood was collected by heart puncture from 6 animals per group and placed in plasma separator 
tubes coated with lithium heparin (BD Microtainer, Franklin Lakes, NJ). The samples were 
separated following the manufacturer’s instructions.  The plasma was sent to Antech Diagnostics 
(Pittsburgh, PA) for measurement of liver function tests (AST, ALT, Cholesterol, and Albumin).  
The average values were plotted ± S.E.M.; significance was calculated using the Student’s two 
tailed t-test; p values less than 0.05 were considered significant. 
SA-β-Galactosidase Assay 
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SA--galactosidase (SA--gal) staining was performed as previously described [16] on 6μM 
frozen liver sections from 20 week-old WT, 20 week-old Ercc1
-/Δ
, and 26 month-old WT.  
Sections were fixed with 2% PFA and 0.25% glutaraldehyde for 5 min at room temperature, 
washed 3 times with PBS, and incubated overnight at 37°C, 20% CO2 in the SA-β gal staining 
solution.   
Immunoblotting 
Flash frozen liver tissue was weighed and sonicated in NETT buffer (100mM NaCl, 50mM Tris 
pH 7.5, 5mM EDTA pH 8.0, 0.5% Triton-X) with Protease Inhibitor Cocktail Set III 
(Calbiochem, Gibbstown, NJ).  For immunodetection of p16 and laminin, 50μg of total protein 
from each liver sample was boiled in 4X loading buffer [0.25mol/L Tris-HCl (pH 8.5), 8% SDS, 
1.6mmol/L EDTA, 0.1mol/L DTT, 0.04% bromophenol blue, 40% glycerol] and separated by 
SDS-PAGE on a 4-20% Mini-PROTEAN gradient gel (Bio-Rad, Hercules, CA), and transferred 
to nitrocellulose membrane.  Rabbit anti-p16 (clone M-156, Santa Cruz Biotechnology, Santa 
Cruz, CA), rabbit anti-laminin (1:2500, a gift from Simon Watkins) and rabbit anti-tubulin 
(1:1000, ab4074, Abcam, Cambridge, MA), followed by an AP-conjugated anti-rabbit IgG 
secondary antibody (1:1000, S-373, Promega, Madison, WI).  Blots were developed in the 
presence of Western Blue® Stabilized Substrate for Alkaline Phosphatase (Promega, Madison, 
WI) and imaged using the Alpha Innotech Red (Santa Clara, CA) gel imaging system.  
Densitometry was calculated using the spot density software on the Alpha Innotech Red gel 
imaging system. 
Quantitation of nuclear size 
Frozen liver sections were fixed with 2% paraformaldehyde and coverslips attached with 
VectaShield mounting medium with DAPI (H-1500, Vector Labs, Burlingame, CA).  Ten 
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random images per sample (n=3 mice per group) were acquired using an Olympus BX51 
fluorescent microscope.  Nuclear size was measured using MetaMorph imaging software to set 
an inclusive threshold to select for hepatocyte nuclei.  Greater than five hundred nuclei were 
analyzed for each experimental group.  Average nuclear size is shown ± S.E.M. p-values were 
derived using a standard Student’s t test with a two-tailed distribution.   
Microarray hybridizations 
Standard procedures were used to obtain total RNA (Qiagen, Valencia, CA) from the liver of 5- 
and 16-week old Ercc1
-/Δ
 mice and WT littermate controls (6 mice per group). Synthesis of 
double-strand cDNA and biotin-labeled cRNA was performed using the GeneChip Expression 
3’-Amplification IVT Labeling kit according to the manufacturer’s instructions (Affymetrix, 
Santa Clara, CA). Fragmented cRNA preparations were hybridized to full mouse genome 
oligonucleotide arrays (Affymetrix, mouse 430 V2.0 arrays), using Affymetrix hybridization 
Oven 640, washed, and subsequently scanned on a GeneChip Scanner 3000 (Affymetrix, Santa 
Clara, CA). Initial data extraction and normalization within each array was performed by means 
of the GCOS software (Affymetrix, Santa Clara, CA). Expression intensities were log 
transformed and normalized within and between arrays with the quantile normalization method 
using the R open statistical package (http://www.r-project.org/).  
Microarray data analysis 
Two-tail, pair-wise analysis or a two-way analysis of variance was used to extract the 
statistically significant data from each group of mice by means of the Spotfire Decision Site 
software package 7.2 v10.0 (Spotfire Inc., Somerville, MA). The criteria for significance were 
set at p≤0.05 and a ≥ ±1.2-fold change in gene expression. We used the bivariate correlation 
procedure to compute Spearman's rho coefficient, a non-parametric measure of correlation that 
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assesses how well an arbitrary monotonic function describes the relationship between two 
variables without making any assumptions about the frequency distribution of the variables by 
means of the statistical package SPSS 12.0.1.  By scoring for qualitative rather than quantitative 
similarities, this approach disregards variations in the magnitude of gene expression that might 
originate from, for example, differences in genetic background, sex or animal housing 
conditions. 
Quantitative Real Time PCR Evaluation 
Total RNA was isolated from the liver of 5 and 16-week old Ercc1
-/Δ
 and WT mice, and 130 
week-old WT
 
mice using a Total RNA isolation kit (Qiagen, Valencia, CA) as described by the 
manufacturer. Quantitative PCR (Q-PCR) was performed with a DNA Engine Opticon device 
according to the instructions of the manufacturer (MJ Research). Primer pair designed to 
generate intron-spanning products of 180-210bp are available upon request. The generation of 
specific PCR products was confirmed by melting curve analysis and gel electrophoresis (using 
Roche Agarose MS for analyzing small PCR products). Each primer pair was tested with a 
logarithmic dilution of a cDNA mix to generate a linear standard curve (crossing point (CP) 
plotted versus log of template concentration), which was used to calculate the primer pair 
efficiency (E = 10
(-1/slope)
). Hypoxanthine guanine phosphoribosyltransferase1 (Hprt-1) mRNA 
was used as an external standard. For data analysis, the second derivative maximum method was 
applied: (E1gene of interest 
CP (cDNA of wt mice - cDNA of Ercc1-/Δ) gene of interest
)/ (Ehprt-1 
CP (cDNA wt mice- cDNA of 
Ercc1-/Δ) hprt-1
). 
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2.3 RESULTS 
2.3.1 Histopathological changes in Ercc1-/Δ liver mimic normal aging 
To investigate structural changes in the liver of progeroid Ercc1
-/Δ
 mice we compared 
liver tissue of 20-24 week-old Ercc1
-/Δ
 mice to wild-type (WT) littermates and to 26-34 month 
old WT mice.  The relative liver/body weight of Ercc1
-/Δ
 mice was not significantly different 
from littermate controls at any age[158].  The architecture of the Ercc1
-/Δ
 liver was irregular, 
with mild to moderate variation in lobular size (Figure 1A).  Pathologic changes detected in both 
Ercc1
-/
 mice and old WT mice include multifocal degeneration, necrosis and neutrophilic 
inflammation, a diffuse increase in sinusoidal lining cells, and karyomegaly, with intranuclear 
inclusions (Figure 1 and 2). None of these changes were detected in young adult (20-24 week-
old) WT mice. The only abnormalities detected in juvenile (7 wk-old) Ercc1
-/Δ
 mice were mild 
anisokaryosis and intranuclear inclusions. Liver from aged WT mice, like humans, displays mild 
portal fibrosis (Figure 1B) and increased neutral lipid accumulation (Figure 1C). Similar changes 
were detected in 20-24 wk-old Ercc1
-/Δ
 mice, but not age-matched WT mice or 7 wk-old Ercc1
-/Δ
 
mice. This demonstrates that the Ercc1
-/Δ
 mice undergo progressive degenerative processes, 
rather than having developmental liver abnormalities. 
Stellate cells are pericytes that reside between hepatocytes and endothelial cells lining the 
sinusoids in the extracellular space of Disse.  Stellate cells store fat and when activated produce 
extracellular matrix proteins, contributing to fibrosis. With aging in humans, stellate cell number, 
but not activity is reported to increase[162].  Stellate cells also increase in number in 3 year-old 
WT mice and progeroid Ercc1
-/Δ
 mice, as measured by desmin and α-smooth muscle actin 
(SMA) staining, markers of stellate cells and their activation, respectively (Figure 1D). Kupffer 
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cells, resident liver macrophages, are also reported to increase in number and phagocytic activity 
with aging in humans [163].  However, we did not detect increased F4/80 immunostaining, a 
macrophage marker, in liver sections of old WT or progeroid mice (Figure 3).  
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Figure 1. Premature onset of age-related liver pathology in Ercc1
-/Δ
 mice 
 (A) Hematoxylin and eosin (H&E) stained liver sections from 7 wk, 23 wk, and 34 mth-old WT mice, and Ercc1-/Δ 
littermates (10X).  The bottom right panel is a high magnification (40X) image of Ercc1-/ liver (23 wk) illustrating 
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inflammatory infiltrate (black arrows), abnormal nuclei with inclusion (green arrows) and dead hepatocytes (blue 
arrows). (B) Masson’s trichrome stained liver sections.  Insets (40X) in the bottom right panel show perisinusoidal 
fibrosis in Ercc1-/Δ and old WT liver samples.  (C) LipidTOX™ stain of liver sections to detect neutral lipids (20X). 
(D) Immunofluorescence detection of desmin and -SMA, markers of hepatic stellate cells and their activation, 
respectively, in frozen liver sections (20X). 
 
 
 
 
 
 
Figure 2. Age-related structural changes in Ercc1
-/Δ
 mouse liver 
Hematoxylin and eosin (H&E) stained liver sections from 7 wk, 23 wk, and 34 mth-old WT mice, and Ercc1-/Δ 
littermates (40X).  The bottom right panel illustrates abnormal nuclei seen in 23 wk-old Ercc1-/Δ and old WT mice. 
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Figure 3. Kupffer cells do not increase in number in Ercc1
-/Δ
 liver 
Immunofluorescence detection of F4/80, a marker of Kupffer cells in frozen liver sections (20X).  
 
2.3.2 Ultrastructural changes in progeroid Ercc1-/Δ mouse liver 
Age-associated endothelial changes in the liver are prominent and contribute to age-
related decline in liver function[164].  Expression of CD31, a marker of endothelium, was 
dramatically increased in 5 month-old Ercc1
-/Δ
 mice and 2.5 year-old WT mice compared to 
young adult WT mice (Figure 4A), indicative of pseudocapillarization. Pseudocapillarization 
encompasses many alterations including thickening of the sinusoidal endothelial cells (LSECs) 
and increased deposition of basement membrane proteins in the space of Disse[149, 165].  
Transmission electron microscopy of liver from old and progeroid mice revealed a thickening of 
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the basement membrane (Figure 4B). This was confirmed by immunblot detection of the 
basement membrane protein laminin, which revealed a dramatically increased level of laminin in 
old WT and 20 week-old Ercc1
-/Δ
 mouse liver compared to young adult WT mice (Figure 4C).   
 
 
Figure 4. Age-related thickening of the sinusoidal endothelium in Ercc1
-/Δ
 mouse liver 
(A) Immunofluorescence detection of CD31, a surface marker of endothelial cells in frozen liver sections (20X).  
(B) Transmission electron micrographs (TEM; 12,000X)  of liver illustrating thickening of the basement membrane 
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in sinusoids of mutant and old WT mice compared to young WT. Insets show enlargement of a portion of the 
original image and arrows indicate deposition of basement membrane and pseudocapillarization of the sinusoidal 
endothelium.  (C) Immunoblot to detect the extracellular matrix protein laminin in liver lysates from 20 wk-old 
Ercc1-/Δ mice, control littermates and old WT (2-3 year) mice (n=3 per group). Densitometry was used for 
quantification and averages are listed as a ratio compared to 20 week-old WT mice.    
 
 
 
With advanced age LSECs also lose their fenestrations, necessary for lipoprotein 
filtration, endocytosis, and immunological functions[164].  Scanning electron microscopy of 
murine liver sections revealed a significant reduction in fenestration of the sinusoids in old (26-
30 month-old) WT mice compared to young (20 week-old) WT animals (Figure 5A).  
Micrographs from 20 week-old Ercc1
-/Δ 
mice looked more similar to those from the old WT mice 
than to their WT littermates, with significantly reduced fenestrations, decreased porosity, and 
loss of sieve plates (Figure 5A-5B).   
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Figure 5. Premature defenestration in Ercc1
-/Δ
 mouse liver 
(A) Scanning electron micrograph (10,000X) of liver, illustrating defenestration in sinusoids of mutant and old WT 
mice. Insets show enlargement of a portion of the original image.  (B) Quantification of porosity shown in A.  3 
SEM images per mouse (n=3 mice per group) were quantified, and the % open area of the sinusoid is represented ± 
S.E.M.  Asterisks indicate significant differences. (C) Serum cholesterol and (D) triglyceride levels in WT and 
Ercc1-/ mice of various ages. The average ± S.E.M. are plotted (n=6 for 7 wk-old mice, n=9 for 21 wk-old and old 
WT mice). Asterisks indicate significant differences as calculated by a paired Student’s t test. 
 
 
Age-related LSEC defenestration can lead to impaired hepatic clearance of atherogenic 
lipoproteins, contributing to hypertriglyceridemia, hypercholesteremia and vascular disease[166, 
167]. Therefore we measured serum cholesterol levels in the mice. Cholesterol levels were 
normal in young (7 wk-old) Ercc1
-/Δ
 mice (Figure 5C). By 21 weeks of age, when defenestration 
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was apparent, serum cholesterol was significantly elevated in Ercc1
-/Δ
 mice compared to WT 
littermates.  In contrast, serum triglycerides were significantly lower in 21 week-old compared to 
littermate controls (Figure 5D). Serum lipoproteins were not significantly altered in old WT mice 
compared to young WT mice.  
 
2.3.3 Functional changes in Ercc1-/Δ mouse liver  
Under normal conditions hepatocytes are quiescent cells, but can be stimulated to 
proliferate in response to parenchymal damage[168].  In an experimental setting, proliferation is 
induced by partial hepatectomy (PHx), which leads to compensatory hyperplasia. Hepatocyte 
proliferation in response to PHx is significantly decreased in aged rodents compared to young 
animals[145].  Thirty-percent of the liver was surgically resected from 10 wk-old WT and Ercc1
-
/Δ
 mice.  Ercc1
-/Δ
 mice did not survive a standard PHx, which removes 70% of the liver. Thus the 
surgery was modified to only remove 1 lobe, or 30% of the liver.  At 48 hours post-resection, the 
mice were euthanized and liver tissue collected for analysis.  Previous experiments in which WT 
mice were euthanized every 12 hours post-partial hepatectomy, from 12-72 hours, indicated that 
48 hours was the time point at which proliferation was the highest in 10 week-old WT mice (data 
not shown).  Immunohistochemical staining for the proliferation-associated antigen Ki67 
revealed a significant decrease in the number of proliferating cells in the liver from Ercc1
-/Δ
 mice 
compared to WT littermates (Figure 6A).  Therefore regenerative capacity of the liver is 
prematurely reduced in Ercc1
-/Δ
 mice. 
To further monitor liver function and integrity, liver function tests were performed on 
plasma of Ercc1
-/Δ
 and WT mice at multiple ages (Figure 6B).  ALT was significantly elevated in 
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old WT mice compared to young, as previously reported[169]. ALT was also significantly 
elevated in Ercc1
-/Δ
 mice compared to age-matched WT mice, even at 7 wks of age. ALT levels 
more than doubled as the Ercc1
-/Δ
 mice aged.  AST was also significantly elevated in old WT 
and 21 wk-old Ercc1
-/Δ
 mice compared to young adult WT mice. Serum albumin is known to 
decrease with age in humans and rodents[170, 171].  Albumin was significantly reduced in the 
plasma of 21 wk-old, but not 7 wk-old Ercc1
-/Δ
 mice (Figure 6B).  Thus, a very similar pattern of 
time-dependent changes in liver function tests, indicative of chronic, progressive tissue 
degeneration and loss of organ function, are observed in Ercc1
-/Δ
 and WT mice. However, the 
changes are dramatically accelerated in the Ercc1
-/Δ
 mice.  
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Figure 6. Premature loss of liver function in Ercc1
-/Δ
 mice 
(A) Representative liver sections from 10 week-old WT and Ercc1-/Δ mice immunostained for the proliferation 
marker Ki67 48 hr post-partial hepatectomy. The fraction of proliferating hepatocytes is graphed (5 random fields of 
view analyzed from n=4 mice per genotype; asterisk indicates p<0.05, Student’s two tailed t-test). (B) Serum 
chemistries reflecting liver function. Plotted are the average ± S.E.M. for 6 mice per age and genotype. WT animals 
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are graphed in reds; Ercc1-/Δ mice in blues. Darker colors indicate increasing age. AST is aspartate transminase; 
ALT is alanine transaminase. Asterisks indicate significant differences. 
 
2.3.4 Increased cellular senescence in Ercc1-/Δ and old WT liver 
To further investigate the mechanism driving the loss of regenerative capacity in Ercc1
-/Δ
 
and old WT mice, we asked if hepatocytes were undergoing cellular senescence. Liver sections 
were stained to detect senescence-associated β-galactosidase (SA-β gal) activity, a marker of 
cellular senescence (Figure 7A).  SA-β Gal staining was increased in liver of 20 week-old Ercc1-
/Δ
 and old WT mice compared to 20 week-old WT mice. p16
INK4a
 is another established marker 
of senescent cells[172].  p16
INK4a
 expression was increased 1.4- and 2.0-fold in 20 wk-old Ercc1
-
/Δ
 and 2 yr-old WT mice, respectively, compared to young WT mice (Figure 7B). Increased cell 
size, nuclear size, and the nuclear:cytoplasmic ratio are also associated with cell senescence and 
old age[173-175].  The nuclear size of hepatocytes was heterogeneous in Ercc1
-/Δ
 and old WT 
mice compared to 7 and 23 wk-old WT mice (Figure 7C). Hepatocyte nuclei of Ercc1
-/Δ
 mice 
were significantly larger than that of WT littermates at 7 wks of age, and increased by 21 wks of 
age (Figure 7C). Nuclear size was also significantly increased in old WT mice compared to 
young WT mice. Electron micrographs revealed a highly irregular surface area of the hepatocyte 
nuclei from Ercc1
-/Δ
 and old, but not young, WT mice (Figure 7D). 
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Figure 7. Premature senescence of Ercc1
-/Δ
 mouse liver 
(A) Senescence-associated (SA) β-galactosidase histochemical stain on flash frozen liver sections. (B) Immunoblot 
detection of the senescence marker p16INK4a  in liver lysates of a 20 week-old WT mouse and an Ercc1-/Δ littermate, 
and a 26 month-old WT mouse. Tubulin was used as a loading control to calculate the fold-increase in p16 
expression relative to adult WT mice. (C) DAPI staining of hepatocyte nuclei illustrating increased nuclear size and 
heterogeneity in old WT (34 months) and adult Ercc1-  mouse liver (1000X).  Quantification of nuclear size using 
Metamorph imaging software and images of DAPI-stained frozen liver sections. Plotted are the average nuclear 
areas ± S.E.M. calculated from 10 random fields from 5 mice per group. The asterisks indicate significant 
differences. (D) Transmission electron micrographs of representative hepatocyte nuclei (12,000X). 
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2.3.5 Increased oxidative damage in Ercc1-/Δ liver  
Oxidative stress has been implicated in driving age-dependent cellular senescence[176].  
To determine if oxidative stress is elevated in Ercc1
-/Δ
 mice and with old age, we measured lipid 
peroxidation in liver. The level of lipid hydroperoxides, measured by ELISA, was elevated in the 
liver of 20 wk-old Ercc1
-/Δ
 mice compared to WT littermates (Figure 8A). A similar elevation 
was seen in old WT mouse liver compared to young WT.  This increase in lipid peroxidation was 
confirmed by immunodetection of acrolein, a stable product of lipid peroxidation.  Ercc1
-/Δ
 and 
old WT mice had significantly increased acrolein compared to adult WT mice (Figure 8B).   
One of the most common markers of aged liver is the cytoplasmic accumulation of 
lipofuscin, which is highly oxidized lipid material[147]. Lipofuscin granules, which fluoresce at 
488nm, were 30-fold elevated in liver of 20 week-old Ercc1
-/Δ
 mice compared to WT littermates 
(Figure 8C).  A similar increase in lipofuscin was observed in old WT mouse liver compared to 
young WT mice.  
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Figure 8. Increased oxidative damage in liver of old and progeroid mice 
(A) Immunodetection of lipid hydroperoxides, a by-product of lipid peroxidation, in liver lysates from 20 wk-old 
WT and Ercc1-/Δ littermate mice vs. old WT mice (26-34 months of age). The box plot represents the mean (in 
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colored square), along with the 25th and 75th percentile for each group (n=5 mice).  Average lipid hydroperoxide 
levels for groups were as follows:  20 wk WT (4.8μM/g liver), 20 wk Ercc1-/Δ (7.3μM/g liver; p=0.12, one-tailed 
Student’s t-test), and old WT (7.2μM/g liver). (B) Immunofluorescence detection of acrolein, a by-product of lipid 
peroxidation. The staining intensity was quantified using AxioVision imaging software. Plotted are the averages ± 
S.E.M. determined from analysis of 10 random fields of liver sections from 2 mice per group.  Asterisks indicate 
significant differences. (C) Representative images illustrating lipofuscin accumulation in 20 week-old WT and 
Ercc1-/Δ mice and 26-34 month-old WT mouse liver.  AxioVision software was used for quantification of 10 random 
fields measured from 5 mice per group.  Plotted is the average fluorescence intensity for each group ± S.E.M.  
Asterisks indicate significant differences. 
 
2.3.6 Age-related transcriptional changes in Ercc1-/Δ mouse liver  
Gene expression changes were measured by microarray in liver of Ercc1
-/Δ
 mice and WT 
littermates at 5 and 16 weeks of age.  Genes that were significantly up or downregulated 
compared to WT littermates are shown (Figure 9A).  There is a progressive downregulation of 
genes associated with the IGF-1/GH axis and oxidative phosphorylation in Ercc1
-/Δ
 mice as they 
age compared to WT littermates.  Additionally, genes involved in DNA damage, oxidative stress 
response, cell cycle arrest, and apoptosis were significantly upregulated in 16 week-old Ercc1
-/Δ
 
mice compared to WT littermates.  qPCR was used to confirm the microarray results (Figure 
9B).   
The transcriptional changes observed in 16 week-old Ercc1
-/Δ
 mouse liver are comparable 
to old WT (130 week) mice (Figure 9C).  Spearman’s r correlation indicates that as Ercc1-/Δ 
progeroid mice age from 5 weeks to 16 weeks, their gene expression profiles have increasing 
similarity to old WT mice.   
 55 
 
Figure 9. Age-associated transcriptional reprogramming in liver of Ercc1
-/Δ
 mice 
(A) Significant gene expression changes (p<0.05, two tailed t-test) in the liver of 5- and 16-week old Ercc1-/Δ mutant 
livers as compared to littermate control animals. Note the progressive dampening in the expression of genes 
involved in oxidative metabolism and the GH/IGF1 axis along with the upregulation in the expression of genes 
involved in cell cycle arrest, DNA damage responses, oxidative stress and detoxification (red color: up-regulated; 
green color: down-regulated, FC: fold change, wks: weeks). (B) qPCR measuremtn of mRNA levels of  a subset of 
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genes identified to be differentially expressed in the liver of 16-week old Ercc1-/Δ animals compared to wild-type 
littermates. For each gene, expression levels in the mutant tissue are plotted relative to those of controls (red dotted 
line). Error bars indicate S.E.M. between replicates (n ≥ 4). (C) Spearman’s r correlation reflecting transcriptome 
similarities between the 5 or 16 week-old Ercc1-/Δ and the 130 week-old mouse livers where -1.0 is a perfect 
negative (inverse) correlation, 0.0 is no correlation, and 1.0 is a perfect positive correlation. 
2.4 DISCUSSION 
The human liver undergoes numerous characteristic structural and functional changes 
with increasing age[149].  Structural changes include loss of organ volume, nuclear polyploidy, 
anisokaryosis, and pseuodcapillarization[149, 169, 177]. These changes lead to impaired liver 
function and loss of regenerative capacity.  Not surprisingly, transplanted livers from late-age 
donors have decreased graft acceptance and function[178, 179].   However, the underlying cause 
for these changes remains unknown. 
Non-human primates have been used to study liver aging, but the commonly used species 
Macaca mulatta and Macaca nemestrina can live more than 20 years[180, 181].  Mice are 
shorter-lived and importantly age-related changes characteristic of aged human liver are 
recapitulated in mice, including pseudocapillarization, increased polyploidy, decreased 
hepatocyte number, and increased nuclear size[154-156, 182].  Thus, mice represent an accurate 
model system for studying age-associated liver changes in humans. However, the 3 year lifespan 
of mice still represents a substantial barrier to rapid testing of hypotheses about the causes and 
treatments of liver aging. 
Herein we establish that the structural, functional and regulatory changes that occur in the 
liver of WT mice in their third year of life are recapitulated in the Ercc1
-/Δ
 progeroid mouse 
strain within their 7-month lifespan. There is a highly significant correlation between the 
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genome-wide expression profile of 4 month-old Ercc1
-/
 mice and 32 month-old WT mice 
(Figure 7). Both have elevated LFTs and reduced regenerative capacity, as well as focal necrosis, 
inflammation, anisokaryosis, and steatosis (Figures 1 and 4).  Markers of cellular senescence 
(SA-βgal and p16) are elevated in livers of progeroid and old mice (Figure 5). This is supported 
by the strong upregulation of genes associated with cell cycle arrest (Figure 7) and the 
observation that livers of Ercc1
-/
 mice, like that of old WT mice[183-185] have reduced 
regenerative capacity following partial hepatectomy (Figure 4). Collectively, these data support 
the conclusion that age-related decrease of liver function is due to dysfunction of hepatocytes 
rather than their attrition. Interestingly, there is accumulation of oxidation products (lipofuscin 
and lipid peroxidation) in the livers of progeroid and old mice (Figure 6), suggesting that 
oxidative damage may drive hepatocyte dysfunction.  
Defenestration and pseudocapillarization, which were significantly elevated in livers of 
Ercc1
-/ 
and old WT mice (Figures 2 and 3), contribute to reduced regenerative capacity[185]. 
Defenestration is also implicated in dyslipidemia due to impaired clearance of lipoproteins from 
the blood to hepatocytes[166].  Serum cholesterol was significantly elevated in progeroid Ercc1
-
/ 
mice compared to littermate controls (Figure 3). In contrast, serum triglycerides were 
significantly lower in mutant animals compared to WT mice. Despite the fact that the extent of 
defenestration was similar in progeroid and old WT mice, serum lipid levels were within normal 
range in the naturally aged mice. Hence the dyslipidemia in the Ercc1
-/ 
mice may reflect 
metabolic changes in the mice rather than a loss of liver transport mechanisms. Indeed, metabolic 
profiling of the Ercc1
-/ 
mice revealed increased serum HDL but decreased LDL and VLDL and 
increased urinary ketone bodies[125].  These changes mimic caloric restriction [186] and occur 
as a consequence genetic reprogramming rather than diminished nutrient intake in the Ercc1
-/ 
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mice (Figure 7 and[113, 125]). The growth hormone/insulin-like growth factor-1 axis is also 
attenuated in Ercc1
-/ 
mice and old WT mice (Figure 7 and[29, 113]).  The decrease in IGF-1 
may contribute to impaired liver regeneration[187]. 
Ercc1
-/ 
mice age rapidly as a consequence of an engineered mutation in the gene that 
encodes one subunit of the DNA repair endonuclease ERCC1-XPF [43], which is required for 
multiple DNA repair pathways [22, 48]. XFE progeroid syndrome, which the ERCC1-deficient 
mice model, is characterized by accelerated aging of the hematopoietic, hepatobiliary, endocrine, 
musculoskeletal and neurological systems[29, 109]. Werner syndrome, caused by mutations in 
WRN, which encodes a DNA repair helicase and exonuclease, is characterized by early onset 
cancer, cardiovascular disease and osteoporosis[188]. Both Ercc1
-/
 and Wrn
hel/hel 
mice display 
early onset of dyslipidemia, steatosis, pseudocapillarization and defenestration in the liver[189]. 
This demonstrates that DNA repair is critical for protecting against loss of liver homeostasis and 
function. Importantly, levels of 8-oxo-deoxyguanine, an endogenous oxidative DNA lesion, are 
greater in old WT mice than young[190-192], consistent with the hypothesis that unrepaired 
DNA damage may contribute to liver aging even in repair-proficient organisms.   
The mice in this study were not exposed to environmental genotoxins. Thus the 
degenerative changes observed are attributed to the accumulation of oxidative damage arising as 
a consequence of normal metabolism. The fact that the onset of degenerative changes are 
accelerated in DNA repair-deficient Ercc1
-/Δ
 mice compared to WT reveals that specifically 
endogenous DNA damage can drive liver degeneration, likely through driving hepatocyte 
senescence[193].  In humans, environmental exposures as well as endogenously produced 
genotoxic by-products undoubtedly contribute to the accumulating burden of DNA damage and 
thereby age-related liver dysfunction. 
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It is important to note that many of the age-related endpoints measured were more 
severely affected in Ercc1
-/
 mice than in WT mice near the end of their respective lifespans. 
This includes LFTs, fibrosis, steatosis, pseudocapillarization, and anisokaryosis. A unifying 
explanation for why the liver of 4-5 month-old Ercc1
-/Δ
 mice looks worse than 2-3 year-old WT 
mice is that the Ercc1
-/Δ
 mice undergo activation of stress response pathways, similar to that 
induced by caloric restriction, which are protective, as the result of accumulated, unrepaired 
DNA damage.  (Figure 7 and [29, 113]).  Thus the Ercc1
-/Δ
 mice survive longer than expected 
given their burden of damage and therefore have extreme aging, comparable to that of 
supercentenarians[158]. Nevertheless, Ercc1
-/Δ
 mice develop the majority of structural and 
funtional characteristics of old human[149] and mouse liver within a matter of five months, 
rather than years.  The vast majority of these changes occur in adulthood (after 7 weeks of age), 
making the changes distinct from developmental abnormalities and degenerative in nature. 
Ercc1
-/Δ
 mice therefore represent an accurate model system for rapidly testing hypotheses about 
the mechanism underlying age-related liver degeneration and pharmacological interventions 
aimed at delaying or ameliorating age-associated liver disease
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3.0  ENDOGENOUS DNA DAMAGE DRIVES CELLULAR SENESCENCE 
Senescence is a cell fate decision in response to DNA damage, chronic oncogenic 
signaling or short telomeres. Cellular senescence is thought to contribute to aging and the 
concomitant loss of tissue homeostasis. However, experimental evidence linking senescence and 
aging, and elucidating the causes of senescence in vivo are lacking. Human fibroblasts undergo 
senescence if challenged with super-physiological doses of genotoxic stress that also damages 
other cellular macromolecules. We employed a genetic approach to specifically ask if 
spontaneous nuclear DNA damage promotes cellular senescence. Ercc1
-/-
 mouse embryonic 
fibroblasts (MEFs) are deficient in nucleotide excision repair, interstrand crosslink repair and 
end-joining of some double-strand breaks.  Ercc1
-/-
 primary MEFs grown at 20% oxygen 
exhibited rapid cellular senescence compared to congenic wild-type cells. This was rescued only 
partially at 3% oxygen and also occurred in ERCC1-deficient mouse tissues.  Remarkably, 
Ercc1
-/-
 cells exhibited significant mitochondrial elongation and dysfunction, likely promoting 
further DNA damage.  Our data provides evidence that physiological levels of endogenous DNA 
damage promote cellular senescence.   
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3.1 INTRODUCTION 
The 21
st
 century has brought a global demographic shift, such that the number of 
individuals over the age of 60 is increasing rapidly in both developed and non-developed nations.  
In 1950, there were approximately 205 million persons over the age of 60 worldwide.  However, 
by 2050 that number is predicted to reach 2 billion[1].  Advanced age is the greatest risk factor 
for numerous chronic degenerative diseases, including cardiovascular disease, arthritis, cataracts, 
glaucoma, osteoporosis, type 2 diabetes, and neurodegenerative disorders such as Alzheimer’s 
disease and Parkinson’s disease.  Eighty percent of individuals over the age of 65 have at least 
one chronic disease and greater than 50% have two or more[194].   In the United States alone, 
the direct medical costs associated with these chronic diseases is estimated to be $582 billion 
annually[195].  In order to improve the quality of life for the elderly, and to minimize the 
economic burden from the medical care of the aged population, it is critical to identify the 
molecular mechanisms that underlie aging. 
Aging is a multifactorial process characterized by the loss of tissue function and the 
decreased ability to maintain homeostasis.  This leads to an impaired ability to respond to stress 
and a dramatically increased risk of morbidity and mortality[12].  At the cellular level, time-
dependent accumulation of damage to macromolecules and organelles is thought to contribute to 
age-related dysfunction.  Currently there is no consensus about the type(s) of damage that are 
most important in driving aging. Types of damage that have been implicated include damage to 
proteins, DNA and mitochondria[196-198]. 
There is a large body of evidence supporting the hypothesis that DNA damage plays a 
causative role in aging.  Mice with inherited defects in DNA repair mechanisms necessary to 
remove damage from the genome develop accelerated aging syndromes, suggesting that DNA 
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damage when not repaired can drive aging[13].  This phenomenon is not limited to mice, as 
humans with inherited mutations in DNA repair genes can also exhibit accelerated aging, or 
progeroid syndromes[14].  In addition, DNA damage induces cellular senescence, which is 
thought to contribute to aging.   
Senescent cells exhibit a large, flattened morphology, irreversible growth arrest, 
increased senescence-associated beta-galactosidase (SA-β-gal) activity, increased expression of 
p16
INK4a
, and persistent nuclear foci containing DNA damage response (DDR) proteins[16, 199-
203].  Senescent cells are more frequently found in the tissues of aged humans, primates, and 
rodents compared to young organisms, and are localized at sites of age-related pathologies, 
suggesting that senescent cells may contribute to age-associated functional decline[16-19, 204].  
However, a direct causal relationship between cellular senescence and aging has yet to be 
established.  
DNA damage activates ATM and ATR, two essential protein kinases involved in the 
DDR.  Subsequently, ATM and ATR phosphorylate and activate downstream kinases, CHK1 
and CHK2.  These signaling events lead to the phosphorylation of p53 on serine 15, and 
upregulation of p21 and p16
INK4a
, leading to the onset of cellular senescence[15, 157, 201, 205].  
DNA is subject to damage from environmental factors such as plant toxins, benzopyrenes, 
ultraviolet and ionizing radiation.  In addition, nucleoside bases can undergo spontaneous 
hydrolysis, resulting in apyrimidinic sites, and single-strand breaks[206].  Reactive free radicals, 
such as hydroxyl radical (
•
OH) produced during aerobic metabolism, can result in damage to the 
bases and phosphodiester backbone of DNA[207-209].  Cellular senescence is a consequence of 
genotoxic stress, and studies aiming to elucidate the mechanism(s) of how DNA damage causes 
cellular senescence have administered ionizing radiation (10-20Gy), doxorubicin (12-800nM), 
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aphidicolin (200ng/ml), etoposide (900nM), and cisplatin (2.2μM) to trigger senescence[203, 
210, 211]. Thus, it is not clear if physiological levels of spontaneous (endogenous) DNA damage 
are sufficient to drive cellular senescence.  Furthermore, all genotoxins, when administered to 
cells or animals, damage not only DNA but also all other cellular macromolecules including 
phospholipids, proteins and RNA [212, 213].  The aim of this study was to understand if there is 
a direct causal relationship between endogenous DNA damage and cellular senescence in vitro 
and in vivo.  
In order to focus solely on the contribution of endogenous, nuclear DNA damage to senescence 
and aging, we took a genetic approach and utilized DNA repair-deficient Ercc1
-/-
 primary mouse 
embryonic fibroblasts (MEFs).  ERCC1 is one subunit of a structure-specific endonuclease 
involved in nucleotide excision repair, interstrand crosslink repair and the repair of a subset of 
DNA double-strand breaks [22, 45, 48].  Mutations that result in a severe reduction of ERCC1-
XPF protein levels result in accelerated aging, in humans and mice[14, 29].  We have found that 
primary Ercc1
-/-
 MEFs undergo premature cellular senescence if grown at 20% and 3% oxygen 
compared to congenic repair-proficient MEFs. In addition, senescent cells were abundant in the 
liver and spleen of ERCC1-deficient mice.   Interestingly, mitochondrial dysfunction and high 
levels of reactive oxygen species accompanied cellular senescence in Ercc1
-/-
 MEFs in response 
to endogenous DNA damage.   
3.2 MATERIALS AND METHODS 
Animal Care and Experimentation 
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All animal studies were conducted in compliance with the US Department of Health and Human 
Services Guide for the Care and Use of Laboratory Animals, and were approved by the 
University of Pittsburgh Institutional Animal Care and Use Committee.  Ercc1
-/-
 and Ercc1
-/∆
 
mice were bred and genotyped as previously described [22, 29].   
Generation and culture of primary mouse embryonic fibroblasts (MEFs) 
Ercc1
-/-
 primary MEFs were developed from embryonic day 12 to 15 embryos derived from 
crossing inbred C57BL/6 mice heterozygous for each null allele, as previously described [22].  
Ercc1
-/-
p53
-/-
 double-knockout primary MEFs were created from embryos derived from crossing 
double-heterozygous mice in an inbred C57BL/6 background.  Genomic DNA was isolated from 
a tissue sample of each embryo with the NucleoSpin DNA extraction system (740741.24, 
Macherey-Nagel, Bethlehem, PA).  Genotyping of the Ercc1 allele was done by PCR co-
amplification of the 3’ end of exon 7 from the wild-type allele and the neomycin resistance 
marker cloned into exon 7 of the targeted allele with primers specific for exon 7, neo, and intron 
7 (5’-AGCCGACCTCCTTATGGAAA, 5’-TCGCCTTCTTGACGAGTTCT, and 5’-
ACAGATGCTGAGGGCAGACT, respectively). WT (0.25-kb) and mutant (0.4-kb) products 
were separated by electrophoresis on a 2% agarose gel. 
Primary MEFs were cultured in a 1:1 mixture of Dulbecco’s modified Eagle’s medium and 
Ham’s F10 with 10% fetal bovine serum and antibiotics and incubated at 3% or 20% oxygen. 
Cell lines simultaneously derived from wild-type (WT) littermate embryos were used as controls 
in all experiments.  
Cell Proliferation Measurement 
Proliferation was assessed as previously described [22]. Briefly, WT and mutant MEFs were 
plated at a density of 0.25 x 10
6
 per 6-cm dish.  Cells were trypsinized at confluence, counted, 
 65 
and replated at the same density until mutant cells stopped growing. The total number of cells at 
each passage was calculated as follows: (no. of cells at previous passage/no. of cells plated) x no. 
of cells at current passage. The total cell number was plotted as the log cell number. 
Immunofluorescence 
WT and Ercc1
-/-
 MEFs were cultured on glass coverslips until they reached 50% confluence. 
Cells were fixed with 2% paraformaldehyde in PBS for 15 minutes. Cells were permeabilized 
with 0.1% Triton X-100 in PBS and the phosphorylated form of γ-H2AX detected with 
monoclonal anti-γ-H2AX (05-636, Millipore, Billerica, MA) and Alexa 594-conjugated goat 
anti-mouse IgG (A-11005, Invitrogen, Carlsbad, CA) in PBS with 0.15% glycine and 0.5% 
bovine serum albumin. γ-H2AX foci were counted with an Olympus BX51 fluorescent 
microscope. 
Immunohistochemistry 
Ki67 staining was performed on deparaffinized tissue sections from 20 wk-old WT and Ercc1
-/Δ 
mice.  Endogenous peroxidase activity was blocked with 3% hydrogen peroxide for 15 minutes.  
Tissue sections were subjected to heat induced-epitope retrieval by incubation in sodium citrate 
buffer (10mM, pH 6.0) for 30 min in a decloaker, followed by 30 min cool-down.  Blocking was 
performed using 5% normal rabbit serum for 20 min at room temperature.  The primary antibody 
for Ki67 (rat anti-mouse Ki67 (TEC-3), M-7249, Dako Cytomation, Carpinteria, CA) was 
applied for 1 hour at a 1:50 dilution at room temperature.  The secondary antibody was applied at 
a 1:300 dilution for 30 minutes, followed by the label antibody (ABC Elite, Vector Laboratories, 
Burlingame, CA) for 30 minutes.  DAB chromagen (Dako Cytomation, Carpinteria, CA) was 
applied for 6 minutes, followed by 2 rinse steps in distilled water.  Hematoxylin was used as a 
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counterstain, and slides were dehydrated, cleared and coverslipped.  Brightfield images were 
collected using an Olympus BX51 fluorescent microscope 
Senescence-associated (SA) β-Galactosidase 
Frozen tissue sections and primary WT and Ercc1
-/-
 MEFs were fixed in 0.25% gluteraldehyde 
and 2% paraformaldehyde for ten minutes at room temperature.  Following three rinses in PBS, 
SA-β-Gal staining was performed as previously described [16, 214]  
Apoptosis Measurement 
WT and Ercc1
-/-
 primary MEFs were stained for apoptosis markers FITC-Annexin V and 
propidium iodide (556547, BD Biosciences, San Diego, CA) according to manufacturer’s 
instructions.  Apoptotic cells were measured on the Cyan LX 9 color high speed flow cytometer 
(Beckman Coulter, Brea, CA) and quantified using Summit v.4.3 software.   
Immunoblotting 
Cells were trypsinized, pelleted, and the pellet was dissolved in ice-cold NETT buffer (100mM 
NaCl, 50mM Tris pH 7.5, 5mM EDTA pH 8.0, 0.5% Triton-X) with Mini-complete protease 
inhibitor tablet (11836153001, Roche Applied Science, Indianapolis, IN).  50μg of whole cell 
lysate was boiled in 4X loading buffer [0.25mol/L Tris-HCl (pH 8.5), 8% SDS, 1.6mmol/L 
EDTA, 0.1mol/L DTT, 0.04% bromophenol blue, 40% glycerol] and separated by SDS-PAGE 
on a 4-20% Mini-PROTEAN gradient gel (Bio-Rad, Hercules, CA), and transferred to 
nitrocellulose membrane.  Primary antibodies against p16 (clone M-156, Santa Cruz 
Biotechnology, Santa Cruz, CA), p21 (ab7960, Abcam, Cambridge, MA), cleaved caspase-3 
(9661S, Cell Signaling Technology, Danvers, MA), beta-actin (ab13822, Abcam, Cambridge, 
MA) and tubulin (ab4074, Abcam, Cambridge, MA) were used at a dilution of 1:500.  This was 
followed by a 1:1000 dilution of either AP-conjugated anti-chicken IgG (ab6878, Abcam, 
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Cambridge, MA), AP-conjugated anti-rabbit IgG (S-373, Promega, Madison, WI), or HRP anti-
rabbit IgG (656120, Invitrogen, Carlsbad, CA).  Blots were developed and imaged using the 
Alpha Innotech Red gel imaging system.  Densitometry was calculated using the spot density 
software on the Alpha Innotech Red gel imaging system. 
Measurement of reactive oxygen species 
H2-DCFDA (C6827, Invitrogen, Carlsbad, CA) was used to measure general oxidative stress 
levels in primary WT and Ercc1
-/-
 MEFs.  10mM H2-DCFDA in DMSO was diluted in PBS to a 
final concentration of 10μM in PBS and added to cells in 10 cm dishes for 20 minutes at 37°C.  
Following incubation, cells were scraped, pelleted, and resuspended in 1 ml PBS.   H2-DCFDA 
fluorescence intensity was measured on the Cyan LX 9 color high speed flow cytometer 
(Beckman Coulter, Brea, CA) and quantified using Summit v.4.3 software. 
To measure superoxide anion levels, WT and Ercc1
-/-
 MEFs were grown in 10-cm dishes to 80-
90% confluency and rinsed with PBS once.  MitoSox reagent (M36008, Invitrogen, Carlsbad, 
CA) was diluted to a 2.5mM stock solution and applied to cells diluted 1:1000 in PBS for a 
2.5μM working solution.  Cells were incubated for 20 minutes at 37°C and scraped, pelleted and 
resuspended in 1 ml PBS.  MitoSox fluorescence intensity was acquired on the Cyan LX 9 color 
high speed flow cytometer (Beckman Coulter, Brea, CA) and quantified using Summit v.4.3 
software.  
JC-1 measurement 
Mitochondrial membrane potential was assessed using the cationic carbocyanine dye, JC-1 (T-
3168, Invitrogen, Carlsbad, CA).  Cells were grown on MatTek glass bottom culture dishes at 3 x 
10
4
 cells/ml.  Cells were washed once in PBS and incubated for 30 minutes at 37°C in serum-
free DMEM with 1.0μg/ml JC-1.  Following wash with PBS, 20 random stage positions were 
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captured at a 40X magnificiation using a Nikon Eclipse Ti microscope equipped with a 
Photometrics CoolSnap HQ2 camera.  n=150 cells were analyzed in 3 independent cell lines for 
WT and Ercc1
-/-
 at 3% and 20% O2 using Nikon Elements image analysis software.   
Measuring ATP 
Cellular ATP levels were measured using the ATPlite™ Luminescence Assay System (6016941, 
Perkin Elmer, Waltham, MA) following manufacturer’s instructions.  WT and Ercc1-/- MEFs 
were grown on 10-cm dishes in either complete MEF media (recipe above) or media with no 
glucose (replaced with galactose).  The following day cells were trypsinized, counted, and 2.0 x 
10
4
 cells were plated in triplicate in 96-well plates.  Cells were immediately lysed and ATP 
levels measured following manufacturer’s instructions.     
Electron microscopy 
WT and Ercc1
-/-
 MEFs were rinsed in PBS and fixed in 2.5% gluteraldehyde in PBS, pH 7.4, for 
1 hour at room temperature.  Following 3 10-min washes in PBS, cell monolayers are post-fixed 
in 1% OsO4 with 1% potassium ferricyanide.  Monolayers are dehydrated in a graded series of 
alcohol (30%, 50%, 70%, 90% for 10 min and 100% 3 times for 15 min).  Cells are immersed in 
Polybed812 3 times, each for 1 hour, and on the third rinse in epon beam capsules are inverted 
over the monolayers and allowed to polymerize at 37°C over night followed by 60°C for 48 
hours.    Beam capsules and underlying cells are removed from the dishes, sectioned, and imaged 
using the JEOL JEM 1011 microscope (JEOL Ltd, Peabody, MA).
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3.3 RESULTS 
3.3.1 DNA repair deficiency accelerates the onset of cellular senescence 
 To determine if spontaneous, endogenous DNA damage can drive cellular senescence, 
we measured multiple parameters associated with senescence in early passage WT and DNA 
repair deficient primary MEFs and followed these parameters with increasing passage number. 
By passage 6, proliferation of Ercc1
-/-
 MEFs was substantially reduced compared to WT MEFs 
cultured at atmospheric (20% O2) (Figure 10A).  The difference in growth rates continued to 
increase with further passaging, until the Ercc1
-/-
 cells ceased to proliferate further at passage 9. 
Growing Ercc1
-/-
 MEFs at 3% O2 (normoxia) partially rescued their growth defect (Figure 10A), 
but did not fully restore proliferation to WT levels. The growth of WT MEFs was also greater at 
3% O2 than 20%O2, although only marginally.  
To decipher if the reduced growth of Ercc1
-/-
 MEFs was due to cellular senescence, three 
markers of senescence were measured:  γ-H2AX foci, SA-β-galactosidase (SA-β-gal) activity, 
and p16
INK4a
 expression.  With increasing passage number, there was a significant increase in the 
fraction of cells with γ-H2AX foci (Figure 10B). Furthermore, if considering the same passage 
number, there was a significantly greater fraction of WT and Ercc1
-/-
 MEFs with γ-H2AX foci in 
cultures grown at 20% O2 than 3% O2. At 20% O2, Ercc1
-/-
 MEFs had significantly more γ-
H2AX foci. These data support the conclusion that γ-H2AX foci, accumulate with time as a 
consequence of oxidative DNA damage.  
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SA-β-gal activity is another hallmark feature of senescent cells. Unlike γ-H2AX foci, a 
significant increase in SA-β-gal was not detected until passage 7 of WT MEFs and only at 20% 
O2 (Figure 10C). Likewise, significantly increased SA-β-gal activity was detected in Ercc1
-/-
 
MEFs grown at 20% O2, but not 3%.O2. However, in the DNA repair deficient cells, there was 
already a significant increase in SA-β-gal activity at passage 3, and this increased significantly 
with further passaging. These data are consistent with the γ-H2AX data indicating that fraction 
of cells undergoing senescence increases over time in culture and that senescence is exacerbated 
by oxidative stress and failure to repair spontaneous DNA damage.  
At passage 3, after only 10-12 days ex vivo, the expression of p16
INK4a
, a third marker of cellular 
senescence, was approximately 2-fold higher in Ercc1
-/-
 MEFs compared to WT MEFs, when 
cultured at 3% or 20% O2 (Figure 10D).  Taken together, these results demonstrate that DNA 
repair deficient Ercc1
-/-
 primary MEFs undergo cellular senescence much more rapidly than 
congenic WT cells.  Senescence is further accelerated by oxidative stress (20% O2 relative to 
3%O2), supporting the conclusion that endogenous oxidative DNA damage can drive cellular 
senescence.  Interestingly, SA-β-gal appears to be a less sensitive marker of cellular senescence 
than either γ-H2AX or p16INK4a. γ-H2AX foci that appear in early passage cells may be caused 
by DNA damage. Alternatively, γ-H2AX foci or p16INK4a expression that occurs in early passage 
cells may reflect transient and reversible events, whereas SA-β-gal activity is characteristic of 
irreversible senescence. 
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Figure 10. DNA repair deficiency promotes the onset of cellular senescence 
(A) Cell proliferation was measured in congenic WT and Ercc1-/- primary MEFs from passage 4 through passage 9 
in split cultures grown at 3% or 20% O2.  Shown is the average of 4 experiments done on independent MEF cell 
lines. (B) Quantification of γ-H2AX foci in WT and Ercc1-/- MEFs at passages 3, 5 and 7 grown at 3% or 20% O2.  
Cells were fixed and immunostained for phosphor-H2AX foci.  Ten random fields were analyzed for each cell line 
and percent of c with foci determined.  The average of 3 independent cell lines is plotted on the graph.  Error bars 
represent ±S.E.M.  Asterisk indicates significance using a two tailed Student's t-test where p<0.05. (C) 
Quantification of SA-β-Gal positive cells in WT and Ercc1-/- MEF cultures at passage 3, 5 and 7 at 3% or 20% O2.  
Cells were fixed and stained with X-gal.  Ten random fields of view were analyzed for each cell line and the percent 
of 100-300 cells staining positively for SA-β-Gal determined.  The average of 3 independent cell lines is plotted on 
the graph.  Error bars represent the S.E.M.  Asterisk indicates significance using a two tailed Student's t-test where 
p<0.05. (D) Immunoblot detection of the senescence marker p16INK4a  in passage 3 WT and Ercc1-/- MEFs cultured 
at 3% or 20% O2. β-actin was used as a loading control to calculate the fold-increase in p16 expression relative to 
WT cells cultured at 3% O2. 
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3.3.2 Ercc1-/- MEFs undergo p53-dependent senescence and not apoptosis 
Cellular senescence as a consequence of genotoxic stress occurs through a p53-dependent 
mechanism a majority of the time[215].  Thus, as further evidence that spontaneous DNA 
damage was driving cellular senescence in Ercc1
-/-
 MEFs, we asked if senescence in these cells 
is p53-dependent. Indeed, genetic deletion of p53 in an Ercc1 knockout background completely 
rescued their proliferation defect (Figure 11A).  Interestingly, the growth of Ercc1
-/-
p53
-/-
 
primary MEFs was significantly greater than WT MEFs, suggesting that even the proliferation of 
repair-proficient cells is limited by oxidative stress.  
In response to genotoxic stress, p53 activates the downstream effector p21 resulting in 
cell cycle withdrawal[216].   p21 expression is >3-fold increased in early passage WT cells 
grown at 20% O2 compared to growth at 3% O2 (Figure 11B). Similarly, there was a 4-fold 
induction of p21 expression in Ercc1
-/-
 MEFs compared to congenic WT cells at passage 3 grown 
at 3% O2 and an approximately 2-fold increase at 20% O2. These results further support the 
conclusion that endogenous oxidative DNA damage drives cellular senescence in Ercc1
-/-
 MEFs, 
and this process may also occur in DNA repair-proficient WT cells.  
To rule out the possibility that proliferation of Ercc1
-/-
 cells was also limited by 
apoptosis, we measured markers of early and late apoptosis. Flow cytometric detection of 
Annexin-V, a marker of early apoptosis, revealed no significant increase in the number of 
apoptotic cells in WT cultures with increasing passage number of increased oxidative stress 
(Figure 11C). Nor was there a significant increase in the DNA repair-deficient Ercc1
-/-
 MEFs 
compared to WT cells.  Interestingly, passage 7 Ercc1
-/-
 MEFs at 3% O2 exhibited higher levels 
of apoptotic Annexin-V/PI+ cells than Ercc1
-/-
 MEFs at 20% O2.  As confirmation, we measured 
expression of cleaved caspase-3, a marker of late apoptosis, in WT and Ercc1
-/-
 MEFs at passage 
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3 and 7 (Figure 11D).   There was a modest increase in cleaved caspase-3 in Ercc1
-/-
 MEFs at 3% 
O2 at passage 7 relative to 20% O2 and WT cells. But there was significant increase in this 
marker of apoptosis Ercc1
-/-
 MEFs compared to WT cells, with increased oxygen tension, or 
increased passage number. We conclude that oxidative DNA damage is not driving apoptosis in 
primary MEFs. 
 
  
 
Figure 11. Cell loss in Ercc1
-/-
 MEF is due to p53-dependent senescence and not apoptosis 
(A) Growth of primary, congenic Ercc1-/-p53-/-, Ercc1-/-, and WT primary MEFs from passage 4 through 7 at 20% 
O2.  The graph represents the average of three independent cell lines of each genotype.  (B) Immunoblot detection of 
p21, a downstream effector of p53, in whole cell lysates of passage 3 WT and Ercc1-/- primary MEFs cultured at 
3% or 20% O2.  β-actin was used as a loading control to calculate the fold-increase in p21 expression relative to WT 
cells cultured at 3% O2. (C) Apoptosis was measured by staining Ercc1
-/- and WT MEFs for Annexin-V and 
propidium iodide (PI) and analyzing by flow cytometry.  The graph represents the percent of cells that were positive 
for both Annexin-V and PI.  The average values obtained from 3 independent cell lines is plotted.  Error bars 
represent the S.E.M.  Asterisk indicates significance using a two tailed Student's t-test where p<0.05. (D) 
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Immunoblot detection of the apoptosis marker cleaved caspase-3 in whole cell lysates of passage 3 and passage 7 
WT and Ercc1-/- primary MEFs cultured at 3% or 20% O2. β-actin was used as a loading control to calculate the 
fold-increase in cleaved caspase-3 expression relative to WT cells cultured at 3% O2. 
 
3.3.3 Cellular senescence occurs in vivo in ERCC1-deficient mice 
 To determine if the premature cellular senescence observed in Ercc1
-/-
 MEFs was an 
artifact caused by ex vivo culture conditions, we measured proliferation and SA-β-gal activity in 
several tissues from ERCC1-deficient mice (Ercc1
-/Δ
).  Ercc1
-/Δ
 mice, which model a human 
progeroid syndrome and age approximately six-fold faster than normal mice, display numerous 
aging-related degenerative symptoms and pathologies by 20 weeks of age[158, 217].  In both 
liver and spleen, there were numerous foci of SA-β-gal in 20 week-old Ercc1-/Δ mice, but not 
WT littermates (Figure 12A).   Similarly, in the spleen and large and small intestine, there was 
much less Ki67 staining, an S-phase antigen and marker of proliferating cells (Figure 12B). 
These in vivo data support the in vitro data. There are more senescent cells in the Ercc1
-/Δ
 
progeroid mice, supporting the conclusion that endogenous DNA damage, if not repaired, can 
drive cellular senescence in vivo.   This data further extends the parallels between Ercc1
-/Δ
 
progeroid mice and old WT mice.  
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Figure 12.  Cellular senescence is observed in vivo in ERCC1-deficient mice 
(A) SA-β gal histochemical stain on sections of liver, spleen and small intestine from Ercc1-/Δ and age-matched WT 
mice.  Images were captured at 20X magnification. (B) Immunostaining for the proliferation marker Ki67 in 
sections of small intestine, large intestine and spleen from Ercc1-/Δ and age-matched WT mice.  Images were 
captured at 20X magnification. 
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3.3.4 Ercc1-/- MEFs exhibit changes in mitochondrial structure 
ERCC1-XPF deficiency leads to genome-wide transcriptional changes that significantly correlate 
with transcriptional changes associated with old age[113, 218].  One of the major biological 
processes that is significantly perturbed in old and progeroid mice is downregulation of genes 
required for the mitochondrial electron transport chain [29, 204].  Thus, we examined 
mitochondrial structure and function in Ercc1
-/-
 MEFs at multiple passages. Transmission 
electron microscopy (TEM) images revealed that even as early as passage 3, the mitochondria in 
Ercc1
-/-
 MEFs are elongated compared to those in congenic WT cells (Figure 13A).  This is 
exacerbated if the cells care cultured at 20% O2.    The mitochondrial phenotype worsened with 
further passaging. By passage 7, the mitochondria in Ercc1
-/-
 MEFs were dramatically enlarged 
in diameter and length, hypodense and diffuse in appearance (Figure 4B). These abnormalities 
were also seen in WT cells at passage 7 albeit to a much lesser extent.  
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Figure 13.  Oxidative stress and DNA repair deficiency promotes structural changes in the 
mitochondria 
(A) Transmission electron micrographs (TEM; 15000X) of passage 3 Ercc1-/- MEFs exhibiting elongated 
mitochondria at both 3% and 20% O2 compared to WT MEFs (B) Transmission electron micrographs (TEM; 
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15000X) of passage 7 Ercc1-/- MEFs exhibiting elongated mitochondria at both 3% and 20% O2 compared to WT 
MEFs.  Affected mitochondria are indicated with red arrows. 
3.3.5 Mitochondria in Ercc1-/- MEFs produce high levels of ROS 
H2-DCFDA is a fluorescent dye used to measure reactive oxygen species [219]. We measured 
H2-DCFDA in primary MEFs with increasing passage number to assess when and if 
mitochondrial dysfunction occurs relative to the onset of cellular senescence. H2-DCFDA was 
significantly increased in Ercc1
-/-
 MEFs at 20% O2 compared to WT MEFs at 20% O2, at 
passage 5 and 7, but not passage 3 (Figure 14A). No significant increase in H2-DCFDA signal 
was detected in WT cells at 20% O2, or between cells cultured at 3% and 20% O2.  
To specifically quantify mitochondrial-derived superoxide anion, WT and Ercc1
-/-
 MEFs were 
stained with MitoSox[220].  Superoxide anion levels were significantly higher in Ercc1
-/-
 MEFs 
at 3% O2 compared to WT cells cultured at 3% O2 at passages 3, 5, and 7 (Figure 14B), 
indicating that endogenous DNA damage results in high levels of superoxide anion.  This 
demonstrates that the increase in ROS occurs simultaneously with the structural changes in 
mitochondria observed by TEM. In addition, growing MEFs at 20% O2, induced significantly 
more superoxide anion production compared to 3% O2 atmosphere. This was true and to the 
same extent in WT and Ercc1
-/-
 MEFs. Interestingly, the level of superoxide anion decreased 
with increasing passage number for cells grown at 20% O2, supporting the notion that by the 
time the mitochondria are elongated, they are no longer producing ROS. These data show a 
particularly strong correlation with conditions that induce cellular senescence (ERCC1-
deficiency, 20% O2), suggesting that mitochondrial superoxide anion precedes and contributes to 
cellular senescence.  
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Figure 14. Oxidative stress and DNA repair deficiency promote increased mitochondrial-derived 
reactive oxygen species 
(A) Oxidative stress was measured with H2-DCFDA by flow cytometry.  WT and Ercc1
-/- MEFs at passage 3, 5, and 
7 were stained with H2-DCFDA and fluorescence intensity was measured by flow cytometry.  H2-DCFDA 
fluorescence intensity is expressed as a ratio to WT MEFs grown under 3% O2.  The average of 3 independent cell 
lines is plotted on the graph.  Error bars represent ±S.E.M.  Asterisk indicates significance using a two tailed 
Student's t-test where p<0.05. (B) Levels of superoxide anion were detected using MitoSox reagent.  WT and Ercc1-
/- MEFs at passage 3, 5, and 7 were stained with MitoSox and fluorescence intensity was measured by flow 
cytometry.  MitoSox fluorescence intensity is expressed as a ratio to WT MEFs grown under 3% O2 (dotted line).  
The average of 3 independent cell lines is plotted on the graph.  Error bars represent ±S.E.M.  Asterisk indicates 
significance using a two tailed Student's t-test where p<0.05. 
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3.3.6 Impaired mitochondrial function in senescent cells 
 To further assess mitochondrial integrity and function, we used JC-1, a cationic dye that 
fluoresces green as a monomer.  JC-1 enters the mitochondrial membrane of live cells and 
aggregates when the membrane potential is high, causing a shift in emission to red.  Live cell 
imaging and quantitative image analysis was used to determine the ratio of JC-1 red 
aggregates:green monomers in WT and Ercc1
-/-
 MEFs.  At passage 3, Ercc1
-/-
 MEFs had lower 
mitochondrial membrane potential compared to WT MEFs, when cultured at 3% or 20% O2 
(Figure 15A).  This indicates that endogenous DNA damage drives loss of mitochondrial 
membrane potential.  In addition, the mitochondrial membrane potential of was significantly 
lower in Ercc1
-/-
 MEFs grown at 20% O2 than the same cells cultured at 3% O2.  A time-
dependent decrease in mitochondrial membrane potential was observed in WT cells at 20% O2, 
and Ercc1
-/-
 cells at both 3% and 20% O2.  This suggests that unrepaired nuclear DNA damage 
caused by ROS can affect mitochondrial function. 
 Another important measure of mitochondrial function is ATP production.  Surprisingly, 
Ercc1
-/-
 MEFs had significantly higher steady-state levels of ATP than WT MEFs (Figure 15B). 
This was true at passage 4 and 6, when a significant fraction of cells were senescent. Curiously, 
the steady-state level of ATP increased for both Ercc1
-/-
 and WT cells with increased passage 
number. Interestingly, when the cells were switched from glucose-containing media to one with 
galactose only, ATP levels dropped. The drop was much more precipitous in Ercc1
-/-
 MEFs than 
WT MEFs. These data indicate that Ercc1
-/-
 cells are much more dependent on glycolysis than 
oxidative phosphorylation for ATP production than are WT cells, which is consistent with their 
gene expression profile that showed reduced expression of electron transport chain proteins[29]. 
In addition, the data suggest that as cells senesce, ATP production is increased via glycolysis.  
 81 
  
 
 
 
Figure 15. Oxidative stress and DNA repair deficiency promote functional changes in the 
mitochondria 
(A) Mitochondrial membrane potential was measured by live-cell imaging using JC-1. The graph represents the ratio 
of JC1 red (aggregates): JC1 green (monomers) for n=150 cells in 3 independent cell lines for WT and Ercc1-/- at 
3% and 20% O2.   Error bars represent ±S.E.M.  * indicates significance using a two tailed Student's t-test where 
p<0.05, and *** indicates p<0.001.  Representative images are shown in the right-hand panels. (B) Steady-state 
ATP levels were measured in WT and Ercc1-/- MEFS at passage 4 and passage 6 at 20% O2 in either complete media 
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which contains glucose or glucose-free media in which galactose was the main sugar source.  The graph represents 
the average of 3 independent experiments ±S.E.M.  *** indicates significance using a two tailed Student’s t-test 
where p<0.001.   
3.3.7 Mitochondrial-derived ROS promotes cellular senescence 
 Table 4 summarizes the senescence-associated and mitochondrial endpoints measured. 
Remarkably, evidence of mitochondrial dysfunction and increased ROS production is detected 
prior to markers of cellular senescence in Ercc1
-/-
 MEFs.  This suggests that mitochondrial 
dysfunction may be a cause rather than a consequence of cellular senescence.  If true, the 
prediction is that cellular senescence could be prevented by attenuating mitochondrial ROS   To 
test this, Ercc1
-/-
MEFs were treated with two free radical scavengers, XJB and Tempol.  XJB and 
Tempol are structurally-related nitroxide radicals that quench cellular free radicals in recycling 
manner.  XJB has an additional gramicidin S moiety that targets XJB specifically to the 
mitochondrial membrane.  Passage 5 Ercc1
-/-
 MEFs at 20% O2 were treated with 2μM of XJB 
and Tempol for a period of 24 hours and total cell number was measured immediately following 
treatment.  Ercc1
-/-
 MEFs exhibited increased proliferation in response to treatment with XJB 
(Figure 16A), demonstrating that mitochondrially-derived ROS does play a causal role in 
promoting cellular senescence caused by endogenous DNA damage.  In addition to measuring 
proliferation, we also observed evidence of decreased SA-β-gal activity in passage 5 Ercc1-/- 
MEFs that had undergone 24 hour treatment with XJB (Figure 16B).   
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Figure 16. A mitochondrial-targeted free radical scavenger decreases senescence in Ercc1
-/-
 MEFs 
(A) Ercc1-/- MEFs at passage 5 plated at equal density were treated with 2μM XJB, 2μM Tempol or nothing for 24 
hours.  The number of cells was measured immediately after removal of the drug, and plotted as a ratio compared to 
untreated Ercc1-/- MEFs, indicated by the dotted line set at 1.  (B) Ercc1-/- MEFs at passage 5 were treated with 2μM 
XJB or 2μM Tempol for 24 hours were fixed and stained for SA-β-gal immediately.  Images are 40X magnification 
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ENDPOINT WT 3% O2 WT 20% O2 Ercc1-/- 3%O2 Ercc1-/- 20%O2 
Passage  3      5 7  3      5 7  3      5 7  3      5 7 
Proliferation -- -- -- -- -- ↓ -- -- ↓ -- ↓↓ ↓↓ 
SA-β Gal -- -- -- -- ↑ ↑ -- -- -- ↑ ↑ ↑↑ 
γ-H2AX -- -- ↑ -- ↑ ↑ -- ↑ ↑ ↑ ↑ ↑↑ 
p16INK4a 1.0   1.2   2.5   2.0   
MT morphology -- -- -- -- -- + + + + + + ++ 
H2-DCFDA -- -- -- -- -- -- -- ↑ -- -- ↑ ↑ 
MitoSox -- -- -- ↑ ↑ ↑ ↑ ↑ ↑ -- ↑ ↑ 
Δψm (JC-1) --  ↓ --  ↓ ↓  ↓↓ ↓  ↓↓ 
Table 4. Summary of senescence and mitochondrial endpoints in WT and Ercc1
-/-
 MEFs 
Endpoints of cellular senescence and mitochondrial function in WT and Ercc1-/- MEFs cultured at 3% or 20% O2.  
Arrows represent increase or decrease at indicated passages (3, 5, or 7).  Pink/red shading indicates an increase; 
green color indicates a decrease.  Numeric values for p16INK4a represent fold increase in p16 protein level, 
determined with normalization to loading control, β-actin.   
 
 
3.4 DISCUSSION 
There is strong evidence that DNA damage robustly induces cellular senescence[203, 
210]. Furthermore, there is strong evidence that defects in DNA repair, causing accumulation of 
DNA damage, accelerates aging of one or more tissues[13, 14]. However it is not known if 
endogenous DNA damage that occurs spontaneously in cells drives cellular senescence, and if 
senescent cells contribute to aging. To test this, we asked if DNA repair deficiency was sufficient 
to drive cellular senescence in vitro and in vivo. Using primary MEFs, it is possible to compare 
 85 
congenic cell lines that differ only in their DNA repair capacity and therefore their burden of 
spontaneous nuclear DNA damage. Ercc1
-/-
 MEFs, with undetectable levels of ERCC1-XPF 
endonuclease were used. Loss of ERCC1-XPF impairs nucleotide excision repair of helix-
distorting DNA monoadducts, the repair of DNA interstrand crosslinks, and the repair of a subset 
of DNA double-strand breaks[22, 45, 48].  Senescence endpoints were measured in untreated 
WT and Ercc1
-/-
 MEFs at multiple passages, to determine if the accumulation of endogenous 
DNA damage is sufficient to induce cellular senescence.  Comparing the same endpoints in cells 
grown at 20% O2 as compared to 3% O2, enabled determination of whether endogenously 
produced ROS promotes genotoxic stress and senescence.  
Based on measurement of numerous markers of cellular senescence, the DNA repair 
deficient cells spontaneously senesce demonstrably more rapidly than WT cells, indicating that 
endogenous DNA damage is sufficient to drive cell senescence.  WT MEFs at 20% O2 do not 
exhibit signs of cellular senescence (SA-β-gal, decreased proliferation) until passage 7.  In 
contrast, Ercc1
-/-
 MEFs at 20% O2 display SA-β-gal, decreased proliferation, γH2AX foci, and 
increased p16 expression as early as passage 3, and these worsen with increasing time in culture 
(Figure 1).  Accelerated senescence is also seen in cultured fibroblasts from patients with ataxia 
telangiectasia (AT) and Werner syndrome (WS)[221, 222].  AT and WS are human diseases that 
result from mutations in ATM kinase, a master regulator of the DNA damage response[223], and 
WRN helicase, required to resolve replication stress particularly at telomeres[224], respectively. 
Patients with AT and WS, like patients with reduced expression of ERCC1-XPF, have symptoms 
of accelerated aging.  In human cells, unlike MEFs, cellular senescence is largely driven by 
replication-dependent telomere shortening[225]. Therefore, our data in MEFs provides novel 
evidence that endogenous DNA damage can drive cellular senescence.   
 86 
Senescence markers were detected earlier and to a greater extent if cells are grown at 
20% O2 compared to 3% O2. p16 expression is modestly increased in passage 3 WT MEFs 
grown at 20% O2 compared to cells grown at 3% O2. SA--gal activity and γH2AX foci are 
increased in WT cells cultured at 20% O2, by passages 5 and 7, respectively, but not if the same 
cells are cultured at 3% O2. Proliferation is reduced by p7 in WT cells grown at 20% O2 relative 
to 3%. Similarly, γH2AX foci, SA--gal activity and impaired proliferation are detected at an 
earlier passage in Ercc1
-/-
 MEFs cultured at 20% O2 compared to the same cells grown at 3% O2. 
This, coupled with the above, strongly supports the conclusion that endogenously produced 
ROS, which is exacerbated when cells are grown at a higher oxygen tension, can drive cellular 
senescence at least in part by causing oxidative DNA damage.  
γH2AX is considered a marker of DNA double-strand breaks, replication stress and 
senescent cells[226, 227]. Interestingly, γH2AX was always detected prior to replicative 
senescence or SA--gal activity. γH2AX foci are significantly increased in passage 7 WT MEFs 
at 3% O2 but there is no observed loss of proliferation. γH2AX foci are significantly increased 
earlier in WT MEFs grown at 20% O2 (passage 5), but SA--gal and proliferation aren’t affected 
until later (passage 7). In Ercc1
-/-
 MEFs, γH2AX foci are significantly increased compared to 
WT cells even at passage 3, for cells grown at 3% or 20% O2.  However, SA--gal activity is not 
increased at passage 3 at 3% O2 and proliferation is not affected until passage 5 or 7. In both WT 
and DNA repair deficient cells, γH2AX foci increase with increasing passage number, reaching 
50% of WT cells and 80% of Ercc1
-/-
 cells with foci by passage 7. These data suggest that the 
γH2AX foci detected early in culture, particularly in the DNA repair deficient cells, are likely to 
be double-strand breaks or replication stress due to oxidative DNA lesions. But those that 
accumulate with increased time in culture, even in WT cells, are more likely to be a phenotype of 
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senescent cells rather than frank DNA damage. This is consistent with γH2AX being a 
component of permanent DNA SCARS, which are defined as DNA segments with chromatin 
alterations reinforcing senescence[203].   
Primary WT and Ercc1
-/-
 MEFs grown at 20% O2 have signficantly higher levels of ROS 
(MitoSox) at passage 5 and p7, compared to the same cells grown at 3% O2. This demonstrates 
that growing MEFs at atmospheric oxygen induces endogenous production of ROS. WT MEFs 
grown at 20% O2 exhibit signs of mitochondrial dysfunction by passage 7, including structural 
changes and reduced membrane potential. This demonstrates that standard culture conditions 
(atmospheric oxygen levels) rapidly induce cellular changes that amplify damage and feed 
forward to drive MEFs to senescence  
DNA repair-deficient Ercc1
-/-
 MEFs also exhibit enlarged and dysfunctional 
mitochondria, but much earlier than WT MEFs, demonstrating a link between a nuclear DNA 
damage and mitochondrial dysfunction. Ercc1
-/-
 MEFs, grown at 3% and 20% O2, exhibit 
enlarged and diffuse mitochondria compared to WT cells, as early as passage 3.  Ercc1
-/-
 MEFs 
also have higher levels of ROS (H2-DCFDA and MitoSox) than WT MEFs, beginning at passage 
5. Similar findings have been reported in S. cerevisiae: DNA repair deficient strains exhibit 
higher levels of ROS[228]. This invokes a model of a vicious cycle in which genotoxic damage 
perturbs mitochondrial function, which in turn leads to increased ROS production and 
consequently more nuclear DNA damage. The fact that this process was accelerated in cells 
defective in nuclear DNA repair, suggests that loss of mitochondrial function is an active process 
rather than passive, i.e., occurring via signaling mechanisms between the nucleus and 
mitochondria, rather than as a consequence of direct mitochondrial damage.  
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Giant mitochondria have been shown to accumulate in aged or damaged cells in response 
to inhibition of autophagic pathways[229].  Hence, nuclear DNA damage or activation of the 
DNA damage response might inhibit autophagy.  Fission and fusion regulate the morphology of 
mitochondria[230]. Thus it is possible that mitochondrial fission-fusion cycles are dysregulated 
in response to nuclear DNA damage. Mitofusin 1 (mfn1), a key regulator of mitochondrial fusion 
and morphology in mammalian cells[231], is significantly downregulated in liver in Ercc1
-/-
 
mice[29], illustrating the potential for abnormalities in mitochondrial fission-fusion cycles, but 
not explaining giant mitochondria.  
Taken together, our data provide experimental evidence that physiological levels of 
endogenous DNA damage can drive cellular senescence.  This is not an artifact of an in vitro 
culture system, as replicative senescence was also detected in tissues of ERCC1-deficient mice.  
Since these mice display accelerated aging of numerous organ systems[14], including the 
liver[204], these data strengthen the link between cellular senescence and aging. Treatment of 
Ercc1
-/-
 MEFs with a mitochondrial-targeted free radical scavenger delayed cellular senescence 
in Ercc1
-/-
 MEFs. This provides evidence that although the DNA damage studied herein, 
occurred spontaneously as a consequence of intracellular processes, it is possible to attenuate this 
DNA damage, which in turn might delay senescence and/or aging-related degenerative changes. 
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4.0  OVERALL SUMMARY AND CONCLUSIONS 
The overarching goal of my thesis was to address the questions; does a direct causal relationship 
exist between cellular senescence and aging, and DNA damage and aging?  I took a genetic 
approach to address this experimental question, and studied mice and cells deficient for ERCC1-
XPF, a essential DNA repair endonuclease.  Mutations that result in severe reduction of ERCC1-
XPF protein levels result in accelerated aging, in humans and mice.  The advantage of this 
genetic approach was that it eliminated confounding genetic variables that often plague human 
studies of aging, as the only difference between inbred mice and congenic (WT and Ercc1
-/-
) cell 
lines was the deficiency of ERCC1-XPF.   Therefore, the differences I observed in ERCC1-
deficient mice and cells compared to WT mice and cells, could be directly attributed to the 
absence of this DNA repair enzyme, and the subsequent effects of endogenous DNA damage.   
The data presented herein demonstrates that physiological levels of endogenously 
produced DNA damage are sufficient to drive cellular senescence both in vitro and in vivo.  The 
first study took an in vivo approach and tested if the accelerated aging phenotype observed in 
ERCC1-deficient mice was similar to normal aging at the molecular, cellular and whole tissue 
level.  This addresses a fundamental question regarding the usefulness of mouse models of 
progeria in the study of human aging.  The liver was the organ I chose to study because the 
degeneration found in Ercc1
-/Δ
 mouse liver was previously implicated as the life-limiting factor 
in ERCC1-null mice[118].   It was my goal to quantitatively and qualitatively characterize the 
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hepatic changes in Ercc1
-/Δ
 mice and directly compare these with the changes that occur with 
normal aging.  The results indicated that the structural and functional changes observed in the 
liver of progeroid Ercc1
-/Δ
 mice over the course of their 6-month lifespan closely paralleled age-
associated changes that occurred in WT mice.  Liver of aged WT and 20 week-old Ercc1
-/Δ
 mice 
both displayed areas of necrosis, foci of hepatocellular degeneration and acute inflammation.  
However, Ercc1
-/Δ
 mice exhibited more severe loss of hepatic architecture, fibrosis, steatosis, 
pseudocapillarization, and anisokaryosis than old WT mice.  The data also indicated that the liver 
of Ercc1
-/Δ
 mice had a reduced capacity for regeneration, as demonstrated by impaired 
hepatocellular proliferation following partial hepatectomy.  Importantly, there was a highly 
significant correlation in genome-wide transcriptional changes between old WT and Ercc1
-/
 
mice.  Taken together, our data indicates that there are strong functional, regulatory and 
histopathological parallels between accelerated aging driven by a DNA repair defect and normal 
aging.    
This study on the effect of endogenous DNA damage in the liver raises an important 
question for future studies on aging; is age-related loss of tissue homeostasis is driven by a cell 
autonomous or non-autonomous effect?  More specifically, is the accelerated liver aging 
observed in DNA repair deficient Ercc1
-/Δ
 mice the result of accumulated damage in the 
hepatocytes, or are resident liver stem cells negatively impacted, leading to a loss of regenerative 
capacity and subsequent tissue dysfunction?  One approach to address this question would be to 
utilize Cre-lox technology to create cell lineage-specific knockouts of Ercc1, and observe the 
effect(s) that result from the loss of functional DNA repair in one specific cell type, such as 
hepatocytes.  Alternatively, parabiosis is another experimental approach to answer this question.  
In the case of where a young WT mouse is fused to an Ercc1
-/Δ
 mouse, if the aging symptoms are 
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alleviated, it will indicate that accelerated aging in response to DNA damage is cell non-
autonomous, and can be ameliorated by a circulating factor from the young WT mouse.   
The second hypothesis addressed in my thesis was that endogenous DNA damage that 
occurs spontaneously in cells is sufficient to drive cellular senescence.  Endogenous DNA 
damage occurs from normal cellular processes at a high frequency.   Endogenous sources of 
DNA damage can result in single-strand breaks, double-strand breaks, and abasic sites, and can 
promote mutagenesis similar to exogenous DNA damaging agents[232].   Previous studies 
determined that high levels of ionizing radiation, doxorubicin, bleomycin, actinomycin D, 
aphidicolin, cisplatin and hydrogen peroxide can induce cellular senescence[210, 211, 233, 234].  
The aim of this study was to determine if physiological levels of endogenous DNA damage 
could drive senescence.  The experiments were carried out using Ercc1
-/-
 primary MEFs, which 
accumulate DNA damage, in the absence of any genotoxic treatment, eliminating off-target 
effects on other cellular macromolecules.  Ercc1
-/-
 MEFs spontaneously exhibited markers of 
cellular senescence, including reduced proliferation, SA-β-gal staining, increased p16INK4a, and 
increased γ-H2AX foci, earlier than WT MEFs cultured under the same conditions.  This result 
indicated that endogenous DNA damage, if not repaired, accelerates the onset of cellular 
senescence.  An unanticipated finding from this study was that mitochondria in Ercc1
-/-
 MEFs 
were elongated compared to WT MEFs and produced more reactive oxygen species, indicative 
of uncoupling of the electron transport chain.  Treatment of Ercc1
-/-
 MEFs with a mitochondrial-
targeted free radical scavenger, XJB, rescued senescence. Furthermore, evidence of 
mitochondrial abnormalities and dysfunction was detected prior to markers of cellular 
senescence in Ercc1
-/-
 MEFs. These data support the conclusion that mitochondrial-derived ROS 
causes DNA damage that drives cell senescence.  Similar mitochondrial and senescence-
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associated changes were detected in WT cells albeit at a later time interval than in Ercc1
-/-
 MEFs, 
indicating that DNA repair mechanisms are inadequate to cope with the normal burden of DNA 
damage and stave off cellular senescence indefinitely. Ercc1
-/-
 MEFs represent a useful in vitro 
model system for assaying pharmacologic interventions aimed at delaying or ameliorating 
premature cellular senescence due to DNA damage. This line of future work is important for the 
thousands of individuals who undergo chemotherapy, oftentimes with a DNA-damaging 
chemical.  Ercc1
-/-
 MEFs are also a useful tool for screening environmental and dietary 
exposures that promote DNA damage and cellular senescence. 
The mitochondrial phenotype observed in Ercc1
-/-
 MEFs presents some exciting 
opportunities for future work.  Transmission electron microscopic analysis of Ercc1
-/-
 MEFs 
revealed an accumulation of dysfunctional mitochondria, a percentage of which appeared to be 
undergoing a specific form of autophagy known as mitophagy.  It is known that aging cells are 
unable to maintain their quality control mechanisms and thus exhibit improper turnover of 
organelles[235].  It is plausible that insufficient or dysfunctional mitophagy could drive the 
accumulation of elongated mitochondria.  Previous work has shown that giant mitochondria 
accumulate in aged or damaged cells in response to inhibition of autophagic pathways[229].  
Preservation or enhancement of autophagic pathways may be a potential therapeutic target for 
ameliorating the mitochondrial phenotype observed in Ercc1
-/-
 MEFs[236].  The direction of 
future studies may also focus on processes of mitochondrial fission and fusion in DNA repair-
deficient cells and animals.  It is likely that mitochondrial fission-fusion cycles are dysregulated 
in response to nuclear DNA damage, as the result of genome-wide transcriptional responses to 
damage.  The gene expression profile of Ercc1
-/-
 mice reveals that there is significant 
downregulation of mitofusin 1 (mfn1) compared to age-matched WT mice[29].  Mitofusin 1 is a 
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key protein in regulation of mitochondrial fusion and morphology in mammalian cells[231].  
Determination of mtDNA replication and mitochondrial biogenesis in Ercc1
-/-
 MEFs would be 
interesting, as reports indicate that DNA damage can induce biogenesis of mitcohondria in an 
ATM and PGC-1α-dependent pathway[237].   
My studies have advanced our knowledge of the cellular response to endogenous DNA 
damage, both in vitro and in vivo.  The signaling mechanisms that are activated in response to 
spontaneous DNA damage will provide clues to a more complete mechanism and potential 
pharmacologic targets for ameliorating or delaying age-related disease and dysfunction. 
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5.0  APPENDIX 
Abbreviation Definition 
ERCC1 Excision repair cross complementation group 1 
NER Nucleotide excision repair 
ICL Interstrand crosslink 
DSB Double-strand break 
CPD Cyclobutane pyrimidine dimer 
COFS Cerebro-oculo-facio-skeletal syndrome 
HR Homologous recombination 
NHEJ Non-homologous end joining 
UDS Unscheduled DNA synthesis 
CS Cockayne syndrome 
IR Ionizing radiation 
ATM Ataxia telangiectasia mutated 
ATR Ataxia telangiectasia and Rad3 related 
DDR DNA damage response 
MEFs Mouse embryonic fibroblasts 
Table 5. Abbreviations 
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Figure 17. Mouse models of DNA repair deficiency: Ercc1
-/-
 and Ercc1
-/Δ 
Representative images of Ercc1-/- (left; 3 wks of age) and Ercc1-/∆ (right; 18 wks of age) mice. 
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Figure 18. Evidence of premature cellular senescence in Ercc1
-/-
 MEFs 
(A) Representative γ-H2AX immunofluorescence images of WT and Ercc1-/- MEFs at passage 3.  Blue color 
represents DAPI staining in nuclei and red foci represent γ-H2AX.   Images were captured at 20X magnification.   
(B) Representative SA-β-gal images of WT and Ercc1-/- MEFs at passage 7.  Blue color represents senescent cells.  
Images were captured at 20X magnification.   
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